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Abstract  
 
Reflectance-based pulse oximetry is a technique used for noninvasively monitoring the oxygen saturation 
(SpO2) and pulse rate (PR). However, there is little supporting evidence that it can accurately collect 
measurements from the chest and wrist.  In this project, a reflectance-based pulse oximeter was built and 
used to collect measurements while sitting, standing, during self-induced hypoxia, and during self-
induced hyperventilation then compared to the measurements taken by a HOMEDIC Deluxe Pulse 
Oximeter. The prototype was able to accurately measure within an error of  + 1% and ±3% for SpO2 and 
PR respectively from the wrist while an error of ±1% and +4% for SpO2 and PR respectively from the 
chest.   
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Executive Summary  
Oxygen saturation (SpO2) is the measurement of oxyhemoglobin (HbO2) in arterial blood. SpO2 is an 
important vital measurement because it shows the levels of blood oxygenation. Traditionally, SpO2 is 
measured by invasively drawing blood samples.  This method, however, is not ideal and  it is unable to 
provide clinicians with real-time measurements. With the need for a noninvasive way to measure SpO2, 
pulse oximetry was developed. The use of this technology allows clinicians to determine SpO2 in patients 
that are sedated, anesthetized, unconscious, or unable to regulate their own oxygen supply. 
 Reflectance-based pulse oximetry allows measurements to be taken from areas of the body in 
which transmittance based pulse oximetry cannot be applied. In reflectance-based pulse oximetry, the 
incident light is passed through the skin and is reflected off the subcutaneous tissue and bone. To this day, 
being able to measure signals from the chest and wrist with one single device has not been successfully 
achieved. Such a device would allow patients to measure SpO2 and pulse rate (PR) without hindering 
their normal day-to-day activities.  
The prototype pulse oximeter constructed during this project consists of two hardware 
components and a programmed LabVIEW Virtual Instrument (VI). The hardware components consist of 
the sensor and a circuit which produces, collects, and processes photoplethysmographic (PPG) signals. 
The VI collects the PPG signals produced by the hardware and process them in order to produce 
numerical results for PR and SpO2 . The optical sensor is made up of two Light Emitting Diodes (LEDs), 
a red LED, with a peak emission wavelength of 660 nm, and an infrared emitter with a peak emission 
wavelength of 940 nm. These LEDs are positioned next to each other in the center of a circular Printed 
Circuit Board (PCB) and surrounded by 8 photodiodes (PD). The circuitry for the sensor consists of an 
Arduino Duo Microprocessor which is programmed to light up the red and infrared LEDs intermittently at 
a frequency of 100Hz. The PDs are connected in photovoltaic mode in order to produce a voltage output. 
Operational amplifiers are utilized to amplify the photodiode output. Once amplified, the red and infrared 
PPG signals obtained from the photodetectors are sent through two Sample-and-Hold circuits to separate 
the signals into their respective alternating current (AC) and direct current (DC) components for further 
filtering and amplification.  
The four input signals sent to the LabVIEW software : AC red, AC infrared, DC red and DC 
infrared access the VI via a National Instruments (NI) Data Acquisition (DAQ) system. The AC 
components of the red and infrared PPGs are measured using a peak-to-peak detection algorithm, while 
the DC components are measured by finding their respective averages. Once the signals are processed, 
SpO2 is calculated by obtaining the ratio of the AC and DC components of the red PPG and dividing that 
by the ratio of the AC and DC components of the infrared PPG. To calculate PR, the frequency of the 
infrared AC signal is measured using frequency measurement parameters in LabVIEW and then 
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multiplied by 60 to display PR in beats per minute (bpm). To compare the measurants taken from the 
pulse oximeter prototype, a transmission-type finger HOMEDICS Deluxe Pulse Oximeter was utilized as 
reference. The reliability of the Deluxe Pulse Oximeter was tested against a Biopac ECG model 100C 
module and was concluded that the HOMEDICS Deluxe Pulse Oximeter was provided accurate enough 
measurements for pulse rate. 
For testing, the sensor was strapped to the wrist and chest of each subject using a Velcro strap 
while the HOMEDICS Deluxe Pulse Oximeter was placed on the subject’s index finger. The VI was set 
up to collect, average and display SpO2 and PR data every 10 seconds throughout a 6 minute timespan 
accounting for 36 measurements. At this point, a second individual that was monitoring the reference 
device recorded the corresponding SpO2 and PR values displayed by the HOMEDICS pulse oximeter. 
Subjects were tested on the chest and wrist while sitting, standing, during self-induced hyperventilation, 
and during self-induced hypoxia.  
While collecting data, it was noticed that the PR measurements collected from the chest had 
significantly larger margins of error compared to those from the wrist. One possible explanation for this 
discrepancy deals with the LabVIEW algorithm for PR calculation. Instead of doing peak-peak analysis, 
we opted to use a search tool which graphs a power spectrum of the data and searches for the highest 
amplitude frequency between 0.75Hz and 2.25Hz. This method is very effective at PR values ranging 
between 45 and 135 bpm, but loses its accuracy at higher PR values. Measurements above 135 bpm were 
detected by the reference, but not accurately detected by the prototype.  
Margins of error obtained from the standing and sitting measurement tests on the wrist included 
0.6%, and 0.2% for SpO2 and 0.2%, 1.1% for PR respectively. Measurements from the chest displayed 
errors of 0.4% and 0.3% for SpO2 and 0.1%, and 0.7% for PR while standing and sitting respectively. 
Based on this data, our prototype for a reflectance-based pulse oximeter for the chest and wrist was 
successful in measuring PR and SpO2.   
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1 Introduction 
One of the most important elements needed to sustain life is oxygen (O2) because it is used by cells to 
turn sugars into useable energy. Oxyhemoglobin (HbO2) is the protein hemoglobin, found in red blood 
cells, bounded to O2 that delivers 98% of oxygen to cells. The measurement and calculation of the 
percentage of HbO2 in arterial blood is known as oxygen saturation (SpO2).
 [1]
 
Originally, SpO2 was measured by taking samples of blood and measuring O2 levels directly. This 
method was invasive and was unable to provide real-time measurements. This measuring technique made 
it impossible for SpO2 to be recognized as an important measure of wellness until a non-invasive method 
of measuring SpO2 in real-time was established. 
[2]
 
The need for a non-invasive method of measuring SpO2 in real-time led to the development of 
pulse oximetry. Pulse oximetry derives SpO2 and pulse rate (PR) from a photoplethysmogram (PPG). The 
PPG is obtained by measuring changes in light absorbed by the blood. Red and infrared wavelengths are 
used to obtain the PPG because these wavelengths are easily transmitted through tissues, allowing SpO2 
to be calculated from the ratio of the absorption of the red and infrared light. 
The first device used to continuously measure blood oxygen saturation of human blood in vivo 
(SaO2) was built by Karl Matthes in 1935. 
[2]
 However, it was not until 1983 that William New and Mark 
Yelderman, after recognizing the need of an accurate oximeter in the operating room evaluated and 
produced the pulse oximeter with aims to make it an intraoperative monitoring device. 
[2]
 Pulse oximetry 
allows for an accurate determination of O2 levels in patients that are sedated, anesthetized, unconscious, 
and unable to regulate their own oxygen supply as well as provides information needed to avoid 
irreversible tissue damage. 
[2]
 
Since the invention of pulse oximetry, the measurement of SpO2 has become an important part of the 
medical world. Nevertheless, improvements such as the application of the reflectance-based technique to 
measure SpO2 from multiple locations on the body are still to be developed. This project demonstrates the 
use of reflectance-based pulse oximetry to obtain measurements for PR and SpO2 from the chest and 
wrist. This development in pulse oximetry technology will pave the way for the development of new and 
novel pulse oximeters that can be worn as accessories, are easily concealed under clothing, and more 
acclimated to use outside of hospital settings. 
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2 Literature Review 
This is a thorough literature review covering the necessary background needed to fully understand this 
project.  
 Oxygen Saturation 2.1
SpO2 is the amount of O2 that is carried in the blood. In the human body, SpO2 is defined as the ratio of 
HbO2 to the total concentration of Hb (reduced Hb + HbO2) present in the blood 
[1]
.  
                         ( )  
      
           
                                      (1) 
Hb is the iron-containing protein in red blood cells that transports O2 to the tissues. This protein 
forms an unstable and reversible bond with O2. Thus, Hb in its oxygenated state is called HbO2 and 
exhibits a bright red color. Conversely, in its reduced state, it exhibits a purplish blue color 
[3]
. Hb can 
carry up to four O2 molecules.  
In calculating the absorption of light at a specific wavelength by a homogeneous substance, the 
Beer-Lambert law can be used to show the basic relationship between the transmitted light intensity and 
the incident light: 
         
                                                                            (2) 
where ‘It’ is the intensity of transmitted light, ‘Io’ is incident light intensity, ‘ε’ is the extinction 
coefficient (fraction of light absorbed at a specific wavelength), ‘c’ is the concentration of the sample, and 
‘d’ is the length of the light path through the sample. However, this is difficult to use in pulse oximetry 
because the light scattering through the tissue cannot be distinguished from that of blood 
[1]
.  
Two independent equations can be derived to describe the absorption of light by both Hb and 
HbO2 at two distinct wavelengths. These equations can then be solved to find the concentration of Hb and 
HbO2 in blood and establish the relationship, 
       
  (  )
  (  )
                                                                  (3) 
where A and B are functions of the extinction coefficients of Hb and HbO2 while ‘OD’ is the optical 
density or the log(Io/It). The relationship above is the underlying principle used by commercial pulse 
oximeters to measure SpO2. 
[1] 
 Pulse Oximetry  2.2
Pulse oximetry was initially intended for monitoring hospitalized patients after surgery. However, after 
recognizing the importance of an accurate oximetry device during surgery in operating rooms, non-
invasive pulse oximetry became a standard for anesthesiologists for intraoperative monitoring since 1990. 
By the use of this technique, physicians can determine the SpO2 in patients that are sedated, anesthetized, 
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unconscious, and unable to regulate their own oxygen supply avoiding irreversible tissue damage 
[2]
. 
It is not until 1935 that Karl Matthes used red and infrared wavelengths to build a device that 
continuously measured SaO2 in vivo. Matthes stated that “the red light can pass through HbO2, but 
reduced Hb absorbs it” [2]. Non-invasive oximetry evolved even further when Robert Brinkman and 
William Ziilstra began measuring SpO2 from the forehead with the use of reflected light. Brinkman and 
Zijlstra made an additional modification when they divided the red signal by the infrared signal to show 
continuous measurements of SpO2 
[2,4]
. However, differentiating various types of Hb was still a problem. 
This is when Robert Shaw invented an absolute reading ear oximeter in 1964. This device used eight 
different wavelengths to identify the separate Hb species present in the blood. Although expensive, this 
instrument was accurate down to 70% of SpO2 and it was commercialized for use in physiology 
laboratories for pulmonary and cardiac applications. 
[2]
 In 1970, research performed by Takuo Aoyagi and 
his associates on dye-dylution techniques for measuring cardiac output led to the development of 
photoplethysmogram (PPG) ,which optically generates time dependent volumetric changes in living 
tissues leading to the development of pulse oximeter 
[1, 2]
. Here, the time dependent changes are associated 
with arterial blood allowing for the measurement of SpO2. Figure 2.1 shows the amount of light absorbed 
by tissue over time. 
 
Figure 2.1: Arterial blood changing over time, PPG [11] 
 
Aoyagi and his associates researched this technique even further and applied it to the already 
existent ear-piece oximeter 
[2]
. Next, in 1977 Minolta Camera developed an oximeter using the same 
method with a fingertip probe and fiberoptic cables from the instrument. Finally, New and Yederman 
produced the Nellcor Pulse Oximeter in 1983 for patients admitted in clinic and hospitals sites 
[2]
. 
 
Improvements on the idea of pulse oximetry led to its reliability to the extent that in 1990 the American 
Society of Anesthesiologists recognized the pulse oximeter as their standard for intraoperative monitoring 
[2]
. 
15 
 
 
2.2.1 Principle of a Pulse Oximeter 
A noninvasive pulse oximeter relies on an optical sensor to detect SpO2 and PR. This optical sensor is 
made up of a red and an infrared LED as well as silicone photodiodes (PD) 
[5]
. In order to obtain SpO2, 
the red wavelength must range within a region where the absorption of Hb and HbO2 are markedly 
different. This is why a red light with a wavelength close to 660nm is chosen as shown in Figure 2. On 
the other hand, the region for the infrared light must revolve around a wavelength where the absorption 
coefficients of Hb and HbO2 are practically the same. This happens between 940nm and 960nm as also 
shown in Figure 2.2 
[1]
. 
 
 
Figure 2.2: Optical absorption spectra of Hb, HbO2, MetHb, and BbCO 
[11] 
The sensor containing the red and infrared LED is applied over the radial artery on the wrist so 
arterial pulsation can be readily sensed. The PDs concentrically located around the LEDs will absorb the 
emission spectra of the red and infrared wavelengths when bounced back from the skin 
[5]
. However, there 
are certain variables that could cause a barrier to the photodiodes from detecting light intensity. These 
include: the opacity of the skin, reflection of light by the bones, light scattered away through the tissues 
and the amount of blood in the vascular bed 
[5]
. Furthermore, when blood flows into the vascular bed onto 
which the sensor is applied, the light emitted by the diodes will have a greater rate of absorption by the 
blood. The light absorbed when the tissue is either full or lacking blood with every heart beat will create 
an alternating light intensity signal. This difference in light intensity created by every heart beat accounts 
to approximately  0.05-1 percent of the whole light intensity that is either transmitted into the skin or 
backscattered into the photodetectors 
[5]
. 
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A pulse oximeter  consists of a circuit that features a microprocessor used to light up the red and 
infrared LEDs one at a time in a synchronous manner, so that when the red light is turned on the infrared 
LED is turned off and vice versa 
[1]
.   With the use of sample-and-hold circuits, the overlapped signal 
acquired by the photodetector can be split into two different analog channels that correspond to the red 
and infrared PPGs 
[1]
.  The red and infrared PPG signals can be further amplified through the 
implementation of high and a low pass filters so that the AC and DC components for each PPG signal can 
be obtained 
[1]
. The new four signals can be processed through a virtual instrument (VI) designed in a 
software program or a virtual instrument that calculates the ratio of AC red and DC red components and 
divides it by the ratio of AC infrared and  DC infrared to produce SPO2.  
2.2.2 Methods of Light Detection 
As previously discussed, pulse oximetry relies on the PPG signals produced by  the difference in the 
amount of  arterial blood, which in turn depends on the systolic and diastolic movements of the heart. 
Measurement of light by the photodetectors can be performed either in transmission or reflection modes.  
When the PPG is measured through transmission, the light source and the photodetectors are placed on 
opposite sides of the vascular bed so that the light travels across the pulsating blood. Thus, this method is 
limited to earlobes, feet, and fingertips. On the other side, reflectance pulse oximetry measures PPG 
signals with LEDs and photodetectors placed on the same side of the sensor surface. This method allows 
measurements to be taken from body parts where the transmission method cannot be used, for example on 
the chest, wrist, and forehead. 
[6]
 
2.2.2.1 Distance Between LED and Photodiode 
In 1988, the effects of separation between the source and detector were studied 
[5]
.
 
Although it is 
understood that the farther away the photodiode and LED are from each other that the readings will 
degrade, it was demonstrated that larger PPGs can be detected by mounting the photodiode further from 
the LED. However, the tradeoff is that higher LED driving currents are required in order to overcome the 
absorption of incident light due to a longer optical path length. Mendelson also shows that by mounting 
more than one photodiode, a greater fraction of backscattered light can be collected and larger PPGs can 
be recorded. 
[5] 
Furthermore, in 2010, there was a similar conclusion regarding the gap sizes between the LEDs 
and the photodiodes 
[7]
. It was found that the amount of light backscattered from the skin on the optical 
module and that was absorbed by the PDs was directly proportional to the number of PDs surrounding the 
LEDs. Thus, the more PDs, the more light would be absorbed.
[8] 
This research showed that 7mm was the 
optimal distance between the LED and PD and produced the highest AC signal. Similar to Mendelson’s 
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research above, a higher current output obtained from a larger number of PDs was required in order to 
obtain a stronger AC components. 
2.2.3 Photoplethysmogram 
PPG is an optical measurement used to represent the volume of blood in vessels used to compute SpO2 
and PR based on the light absorbance of blood. During the cardiac cycle, the amount of blood in tissue 
varies in relation to each heartbeat, so a PPG signal is an optical representation of the cardiac cycle wave. 
This results in a distinguishable AC component. The PPG is usually taken at peripheral sites such as the 
finger, ear, or forehead.  Since skin is perfused by blood, conventional pulse oximeters monitor the 
perfusion of blood in the dermis and subcutaneous tissue of the skin. The AC component of the oximeter 
signal is attributed to variation in blood volume and the DC component of the oximeter signal is generally 
attributed to skin tissue absorption. 
[9;10;11]
  
2.2.4 Wavelength Optimization 
Although wavelengths at which the SpO2 are typically measured are 660nm for red and 910 nm or 940 nm 
for infrared, it is possible to measure SpO2 at different wavelengths and also with more than 2 
wavelengths. In fact, the Hewlett-Packard model 47201 Ear Oximeter which debuted in the 1960s utilized 
8 wavelengths. The advantage to using more than two wavelengths is that it makes it possible to measure 
saturation of more than just oxygen in the hemoglobin chains. However, for the purposes of measuring 
only SpO2, two wavelengths are sufficient.  
Nogawa, in 1998, also showed that by changing the two selected wavelengths from 665/910 nm 
to 730/880nm, a linear relationship could be established for oxygen saturation rates over the 100-30% 
range. In the 70-30% range, the improvement was significant with a standard error of 2.69% as compared 
to 9.49% for a sensor utilizing 665/910nm wavelengths. Results also showed that in the 100-70% range, 
the 730/880 nm sensor showed a slight improvement in the standard error, lowering it from 3.50 to 
2.11%. 
[12]
  
2.2.5 Limitations and Applications of Pulse Oximetry 
There are certain situations in which data processed by a pulse oximeter can be misinterpreted or difficult 
to acquire. Significant reduction in peripheral vascular pulsation due to hypotension, vasoconstriction or 
hypothermia can cause a small signal to be processed unreliably by a pulse oximetry 
[1]
. Also, due to the 
small signal that is analyzed, only 1 to 2% of the PPG signal can be processed, motion artifacts can 
interfere with a proper PR signal reading if the patient is shivering or having a seizure. Increase in venous 
pulsations may also interfere with pulse oximetry resulting in artificially low SpO
2 readings 
[13]
. 
Furthermore, large amounts of dysfunctional Hb, which is Hb derivatives that do not bind reversibly with 
O
2
 like HbCO and MetHb, can lead to an incorrect oxygen saturation interpretation by the pulse oximeter 
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[1]
. Compromised blood circulation, excessive contact pressure or weak PPG signals resulting from 
insufficient contact pressures may also yield to measurement errors 
[14]
. Finally, one of the greatest 
limitations of transmittance pulse oximetry is movement of the patient. By being attached to the finger 
and the fact that extraneous movements can cause a change in absorbance of light by arterial blood flow, 
a conventional pulse oximeter hinders the user to perform regular daily activities 
[14;15]
. 
 Reflectance vs. Transmittance Pulse Oximetry 2.3
With recent achievements in pulse oximetry, the devices are generally characterized as transmission based 
and reflectance based. In transmission based pulse oximetry, LED and a photodiode are placed on 
opposite sides of a substrate, which in turn can be attached across the fingertip, earlobe, and foot.  
 
Figure 2.3: Transmittance pulse oximetry 
In reflectance-based oximeters, the LED are placed together on the same probe surface. This method is 
mainly intended to be used on body locations where pulse oximetry through transmission is not feasible. 
 
Figure 2.4: Reflectance pulse oximetry 
Forehead reflection pulse oximetry is one example and is generally more accurate than transmission type 
pulse oximeters on patients with a low cardiac index or poor peripheral perfusion.
[1]      
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Figure 2.5: Forehead pulse oximeter 
 New Studies for Pulse Oximeters 2.4
One such wrist based prototype relying on reflectance based oximetry is the AMON 
[19]
. This prototype 
endeavored to measure blood oxygen saturation, pulse, blood pressure, skin temperature and ECG data 
using a single ECG lead. However, after conducting a study on 33 healthy volunteers, and comparing the 
data gathered by AMON to that of two commercially available pulse oximeters, the results weren’t 
promising and not every type of measurement was able to be used. Results showed that blood pressure 
data and pulse measurements from SpO2 were satisfactory and as expected, however SpO2 measurements 
were far from expected due to significant deviation. As for ECG, although PR results could be obtained, 
there was no conformity in the QRS and QT complexes of the ECG as results, as well as high levels of 
measurement noise which degraded the results. The lack of conformity and noise made it difficult to 
distinguish the ECG as a waveform. The temperature sensor on the other hand was unsuccessful since  the 
study showed no reliable correlation between the reading at the wrist and the core body temperature. 
[19]
 
A second wrist based pulse oximeter that showed potential is a prototype by Coker et al. in which 
the results were far more promising. For pulse measurements, Coker’s prototype had an accuracy error of 
less than 2% as compared to two different commercial pulse oximeters while the averaged SpO2 
measurements had an accuracy error of less than 1%. However, it is noted that while the prototype 
provided accuracy competitive to that of commercial pulse oximeters, motion artifacts cause signal 
integrity issues and needs to be addressed. Some possible methods of addressing motion artifacts are 
through the use of a motion sensor to account for user movement or much more refined signal processing 
using filters to minimize noise and find the highest signal to noise ratio. 
[16] 
Lastly, a sensor consisting of a multiple photodiode array was arranged concentrically around 4 
LED’s was tested on the forearm and calf [20]. This sensor however also utilizes a heating unit. Previous 
research has shown that heating the skin under the sensor increases the magnitude of the detected pulsatile 
component four- to five-fold. The purpose of this study however was to measure the effectiveness of the 
sensor under controlled hypoxia. Ten volunteers were studied and the inspired fraction of oxygen in the 
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breathing gas mixture was gradually lowered from 100 to 12%. Measurements were simultaneously taken 
from the forearm and calf then compared to SpO2 measurements obtained by a finger sensor. Though the 
experiment was done while the volunteers were standing still and the results are not as ideal as the 
forehead reflectance oximeters 
[20]
. 
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3 Design Approach  
Applying pulse oximetry technology to the chest and the wrist can provide the opportunity to create new 
noninvasive devices that will be less restrictive to a wears’ movements and more comfortable. The 
combination of a different placement and design could further the monitoring of vital signs in settings 
other than hospitals. 
 Initial Client Statement  3.1
Develop a wearable, noninvasive reflectance-based pulse oximeter prototype that demonstrates accurate 
and precise measurements of arterial oxygen saturation and heart rate from the chest and/or wrist on 
healthy volunteers. 
 Clinical Need 3.2
Reflectance-based pulse oximetry allows measurements to be taken from areas of the body in which 
transmittance-based pulse oximetry cannot be used. Using reflectance-based pulse oximetry, the 
wavelengths are passed through the skin and reflect off the bone and tissue in the area of the 
measurement. Being able to receive signals from the chest and wrist has not yet been successfully 
achieved using reflectance-based pulse oximetry. It is difficult to receive signals from the chest and wrist 
because the light needed to create the signal must be reflected back which makes the signal weaker and 
more difficult to detect. Creating a method to obtain a PPG signal strong enough to process for SpO2 and 
PR from the chest and wrist is the central dilemma behind this project. Achieving this could further the 
development of new devices that could be worn during daily activities and as a method of protecting 
servicemen in the field. 
 Design Parameters 3.3
In this section are outlined the various aspects of project designed to address the clinical need behind a 
reflectance-based pulse oximeter for the chest and wrist. These design parameters cover both the 
qualitative and quantitative pieces of the final design.  
3.3.1 Objectives 
The objectives consisted of three categories: ‘Easy to use’, ‘Marketable’, and ‘Safe’. ‘Easy to use’ 
addresses the user friendly nature needed for the device to be useable by the large audience that is to be 
targeted. To be easy to use the device must be easy to wear, operate, or read. ‘Marketable’ addresses the 
need for the device to be successful and competitive on the market. This means that the device must be 
cost-efficient, manufacturable, portable, durable, and comfortable. ‘Safe’ addresses that device must be 
safe for the users. Thus the device must be secured against the user to avoid false measurements, be 
composed of biocompatible materials as not to cause the user adverse reactions, and conduct reliable 
readings. 
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Figure 3.1: Objective tree 
 
3.3.2 Constraints 
Throughout the duration of our project, there were many constraints that the device must overcome. First, 
the device must not restrict the wearer from following their daily activities. There are many sizes the 
device could potentially be, however in order to keep the device from impacting a patients daily activities, 
the device must be kept to a small, concealable size. Second, the device must stay in constant contact with 
the skin. In order for the device to provide accurate results, it must not separate from the wearer at any 
time. The last constraint that the device must overcome is the regulatory requirements. The FDA has 
compiled a set of regulations, which include patient safety, performance requirements, and electrical, 
mechanical and environmental safety. In order for the device to be considered a success it must 
successfully overcome all of these constraints. 
3.3.3 Functions 
In this section is discussed the attributes that allow the prototype designed during this project to function 
properly. 
3.3.3.1 Obtain Photoplethysmogram Signal  
As dictated in the client statement, reflectance-based pulse oximetry was used to obtain the PPG signal 
necessary for computing SpO2 and PR. The theory and method of reflectance-based pulse oximetry will 
Reflectance-
Based Pulse 
Oximetry for the 
Chest and Wrist  
Easy to use  
Easy to wear 
Easy to operate 
Easy to read 
display 
Marketable 
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Portable 
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be used to do this from the chest and wrist.  
3.3.3.2 Measure Heart Rate 
In the AC component from the obtained PPG signal, the pulsatile pattern on the top of the PPG signal 
reflects the changing blood volume at the site of measurement with each cardiac beat. The signals are 
passed through a bandpass filter with a cut-off of about 1.5 Hz, to separate the AC pulses from the DC 
signals. The LabVIEW VI developed to process the PPG signal is then used to average the maximum 
frequency to determine the rate of the cardiac beat in hertz. This value was then multiplied by 60 to find 
the PR in beats per minute. 
3.3.3.3 Measure Oxygen Saturation  
SpO2 is defined as the ratio of HbO2 to the total concentration of Hb present in the blood 
[1]
. After the 
LabVIEW VI processes the PPG signal, it calculates the ratio of red to infrared light used in the 
calculation for SpO2. 
3.3.4 Design Specifications 
The specifications for this prototype were determined from the market standards by selecting several 
commercially available pulse oximeters specifications and examining them. One such device was the 
Respironics’ WristOxTM Ambulatory Finger Pulse Oximeter which entered the market in October of 
2003. Its specifications can be found in Table 3.1. 
[21]
 
Table 3.1: Respironic's WristOx Ambulatory Finger Pulse Oximeter Specifications [21] 
Effective Measuring Range 
Saturation 0% to 100% 
Pulse Rate 18 to 300 bpm 
Resolution 1 digit 
Accuracy 
Saturation 70 to 100% ± 2 digits 
Pulse rate ±3% 
Display 
Numerical 3-digit indicators 
Pulse indicator Pulse Strength Bar Graph 
Power requirement Two 1.5V alkaline N-cell batteries 
Battery life Minimum 24 hours continuous 
Storage 9 months 
Size 
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Weight ~0.88 ounces (24.95g) 
Dimensions (w/o 
sensor or strap) 
1.75” wide x 2” high x 0.75” deep 
4.45cm x 5.08cm x 1.905cm 
 
Another device which is on the market and FDA approved is the Santa Medical’s Finger Pulse 
Oximeter. Its specifications can be found in Table 3.2. 
[7]
 
Table 3.2: Santa Medical's Finger Pulse Oximeter Specifications[7] 
Effective Measuring Range 
Saturation 0% to 100% 
Pulse Rate 18 to 254 bpm 
Resolution ±1 digit 
Accuracy 
Saturation 75 to 99% ±2 digits 
Pulse rate ± 2bpm 
Display 
Numerical 3-digit indicators 
Pulse indicator Pleth bar 
Power requirement Two AAA alkaline batteries or rechargeable 
batteries 
Power 
consumption 
Less than 30Ma 
2.6-3.6V 
Battery life 30 hours continuous 
Size 
Weight 50g including batteries 
 
The final device specifications examined are those of the Crucial Medical System’s Finger Pulse 
Oximeter which is also FDA approved. Its specifications can be found in Table 3.3. 
[22]
 
Table 3.3: Crucial Medical Systems Finger Pulse Oximeter Specifications [22] 
Effective Measuring Range 
Saturation 35% to 99% 
Pulse Rate 30 to 250 bpm 
Resolution ±1 digit 
Accuracy 
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Saturation 70 to 99% ±2 digits 
Pulse rate ± 2bpm 
Display 
Numerical 3-digit indicators 
Pulse indicator Bar graph and perfusion index 
Power requirement Two AAA alkaline batteries 
Power 
consumption 
Less than 30Ma 
2.6-3.6V 
Battery life 30 hours continuous 
Size 
Weight 1.8oz (50g) including batteries 
Dimensions 58.5 x31 x32 mm 
 
The standard parameters to make the prototype in this project competitive by market standards 
were determined after examining the specifications for the Respironics’ WristOxTM Ambulatory Finger 
Pulse Oximeter, the Santa Medical’s Finger Pulse Oximeter, and the Crucial Medical System’s Finger 
Pulse Oximeter. The specifications table for this project’s prototype can be found in Table 3.4. 
Table 3.4: Project Specifications 
Effective Measuring Range 
Saturation 70 to 100% 
Pulse Rate 20 to 250 bpm 
Resolution 1 digit 
Accuracy 
Saturation ± 3% or ± 2 digits 
Pulse rate ± 3% or  ± 3 digits 
Display 
Saturation 2 characters 
Pulse Rate 3 characters 
Power 
Requirement 
3V lithium battery 
(coin sized batteries) 
Battery Life  Minimum 24 hours continuous 
 
 Revised Client Statement   3.4
Develop a wearable, noninvasive reflectance-based pulse oximeter prototype that demonstrated reliably 
accurate and precise measurements SpO2 and PR from the chest and wrist. The prototype connects to the 
computer generated program, LabVIEW, which displays the SpO2 and PR graphically and numerically.  
The prototype measures SpO2 within 70 to 100 percent and PR within 20 to 250 beats per minute having a 
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resolution of 1 digit and accuracy within ±3% or ±3 digits. This prototype should weigh less than 150 
grams.  The prototype must not cause any harm, such as burning the skin or allergic reactions. In order to 
provide the best results possible for SpO2 and PR, the prototype must remain in constant contact with the 
skin. This prototype should be easy to use, requiring little to no training before use. Once the prototype is 
completed, testing for this device was conducted on healthy volunteers to test the accuracy and precision 
as well as proving that SpO2 and PR can be measured from the chest and wrist.    
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4 Device Development 
 Device Alternatives 4.1
4.1.1 Sensor Design 1 
This prototype design utilized a dual-wavelength LED surrounded by 4 photodiodes. These photodiodes 
were positioned at 90° increments around the LED. The LEDs transmitted at 660nm and 940nm. Many 
studies showed that better signal quality can be achieved when a ring of photodiodes are used to collect 
light from a central light source 
[23]
. The separation distance between the LED and each photodiode were 
approximately 1 cm. As a result, the LED required a larger driving current so that more tissue is able to 
absorb and reflect light 
[5]
. A bandpass filter was utilized at a cut off frequency of 2Hz and bandwidth of 
3Hz. This sensor was compatible with flash memory and utilizes a serial connector interface so as to 
make it possible to connect the device to LabVIEW for signal analysis. Further signal processing was 
accomplished by using LabVIEW in order to minimize motion artifacts and noise.  
 
 
 
 
 
 
 
 
Figure 4.1: Sensor design 1.[5] 
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4.1.2 Sensor Design 2 
The other prototype also utilized a dual-wavelength LED surrounded by 4 photodiodes. These 
photodiodes were positioned at 90° increments around the LED. The LEDs transmitted at 730nm and 
880nm. These wavelengths have been shown to provide a more linear relationship for SpO2 values less 
than 70%.  Many studies showed that better signal quality can be achieved when a ring of photodiodes is 
used to collect light from a central light source 
[23]
. The separation distance between the LED and each 
photodiode was approximately 1 cm. As a result, the LED required a larger driving current so that more 
tissue is able to absorb and reflect light 
[5]
. A bandpass filter was utilized at a cut off frequency of 2Hz and 
bandwidth of 3Hz. This sensor was compatible with flash memory and utilized a serial connector 
interface so as to make it possible to connect the device to LabVIEW for signal analysis. Further signal 
processing was implemented using LabVIEW in order to minimize motion artifacts and noise. 
 
Figure 4.2: Diagram of sensor design 2.[5] 
4.1.2.1 Evaluating Alternative Designs 
The most significant difference between the two alternative designs above was the difference in 
wavelengths. In design 1, the most commonly wavelengths, 660nm and 940nm, for oximetry were used 
for the LEDs since they have been proven to work efficiently. In design 2, wavelengths 730nm and 
880nm were explored and investigated to determine if these wavelengths would serve as more efficient 
substitutes. Nogawa showed that with a 730/880nm sensor, a linear relationship could be established for 
the oxygen saturation between 30-100% with the greatest improvement seen at oxygen saturation levels 
between 30-70% 
[12]
. For the purpose of this project, the most commonly used wavelengths, 660nm and 
940nm were selected. For a chest based pulse oximeter, research showed that the upper sternum provides 
decent readings when the user is still 
[24]
.  For the wrist based pulse oximeter, the desired measurement 
location was the radial artery which has shown some success over the ulnar artery on the wrist
 [25]
. 
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 Software Design 4.2
The program used to compute SpO2 and PR from the PPG signals gathered by the sensor is LabVIEW 
System Design Software from National Instruments. Each program created within LabVIEW is known as 
a virtual instrument (VI).  
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5 Methods 
 Photodetection Unit 5.1
The photodetection unit used in this project utilizes LEDs and photodiodes to collect backscattered light 
that travels from the LED, through skin and tissue and is reflected off the bones and subcutaneous tissues 
back into the photodiode. Our ability to measure the PPG and calculate SpO2 comes from the varying 
absorption that occurs as the heart pumps blood through the arteries. For the photodetection unit to 
properly work, the LED and photodiode must be close enough to each other so the photodiode can pick 
up the greatest fraction of backscattered light for the highest possible output and signal to noise ratio. 
 PPG 5.2
The pulse oximeter makes it possible to observe the PPG signal due to the changing of absorbance 
because of arterial blood pulsating throughout the body. In Figure 5.1 below we can see that the PPG 
which is commonly referred to as the pulsatile component or the AC component, is a small percentage of 
the total signal output which is generally riding on top of a large DC offset. This DC offset occurs due to 
absorbencies that are not changing such as skin or other non-arterial tissues which maintain a constant 
absorbance. When attempting to amplify the PPG for closer inspection, it is generally the case that the DC 
component is also amplified and as a result ends up saturating the signal. To properly amplify the PPG 
signal it is best to filter out the DC component through the use of a bandpass or high pass filter. Once 
amplified, the PPG signal can then be used to calculate heart rate either visually or with the aid of special 
software that can calculate the frequency or count the number of peaks in a certain time interval. 
 
 
Figure 5.1: Unfiltered output of a PPG signal with an AC component riding on top of a DC component 
 Filter Design 5.3
To separate the PPG from the output of the photodiodes, it is necessary to filter the signal in such a way 
so that the PPG signal is preserved while other unwanted parts of the signal are attenuated. In the case of 
the PPG and the average pulse rate of a healthy patient, a bandpass filter with a cutoff frequency of 1.5-
2Hz and a narrow bandwidth of 2-3Hz. This will allow for the separation of the AC and DC components 
which is necessary for SpO2 and PR calculations.   
DC 
AC 
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 Software  5.4
Signals were digitized and sampled using LabVIEW DAQ Assistant with analog inputs collected by a 
National Instrument’s Data Acquisition Board with a sampling frequency of 100Hz. The functions of the 
software are described in Appendix A and can provide further detail into the design of the VI used for this 
prototype.  
 
 
 
 
 
 
Figure  is the summarized sequence of software processes which are applied to both the red and infrared 
PPGs.  
 
 
 
 
 
 
 
Figure 5.2: Software flow chart 
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Rate 
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5.4.1 Incoming Signals 
The first block in the Software Flow Chart, in Figure 5.2 is to address the installation of the external DAQ 
Assistant and the completion of its internal task which includes identifying the connected external DAQ 
Assistant with the DAQ Assistant function in the Block Diagram, each of the incoming signal channels, 
and the sampling rate. Since the DAQ Assistant function combines the four incoming signals created by 
the sensor into a single output called data, four Select Signals functions are used to separate and identify 
the incoming signals. The Select Signal functions were used instead of a simple Split Signal function 
because they could be set to single out a one specific signal while a Split Signal would separate the 
signals, but provide no indication of which signal was being produced. To ensure that the DAQ Assistant 
external and internal system was receiving the signals correctly, Waveform Graphs were implemented at 
the output of each Select Signals which when the prototype was running would plot the AC and DC 
components of the red and infrared signals and be compared to the readings of an oscilloscope.  
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Figure 5.2: Configuration of functions to separate incoming signals 
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5.4.2 Filtering 
Next, is the filtering of the red AC signal because of the extra noise that accompanies this signal. The 
infrared AC signal was not filtered digitally because it was a stronger signal due to infrared light not 
being as blood absorbent as red light. A bandpass filtering type was selected because it was necessary to 
eliminate extraneous signal samples above and below the main signal. Since an average pulse rate is 
approximately 60bpm, the amplitude of the signal necessary to produce the average pulse rate is between 
1.5 -2 Hz. This provides the low cutoff with 0.75Hz which is about 40bpm and the high cutoff with 2.5Hz 
which is about 130bpm. The Chebyshev filter topology of the 7
th
 order was implemented because it 
provides a steeper roll-off and minimizes the error between the idealized and the actual filter 
characteristic over the range of the filter. The impact of removing the noise from the signal by using these 
filter parameters can be seen on the sample graphs provided in the Configure Filter menu as seen below.  
 
 
 
Figure 5.3: Configure filter menu 
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In Figure 5.4, the Filter function can be seen connected to a Waveform Graph which allows for 
the visualization of the change of the digital signal after it passes through the filter and confirmation that 
the filter was working. 
 
Figure 5.4: Filter function and graph 
5.4.3 Frequency of Pulse Rate 
Tone Measurements are the function used to determine the frequency of the Infrared AC signal which is 
needed to determine PR. This function has several measurements that it can perform, but for this VI, it is 
only used to measure frequency. Tone Measurements achieves this by searching for the set frequency, 
which is 2±50Hz. This range was chosen because a 2 Hz signal results in the average pulse rate of 
approximately 60bpm, but pulse rate can vary from 40bpm to 150bpm thus the ±50Hz range.  In Figure 
5.5, the Tone Measurement function can be seen connected to both a Numeric Indicator and Waveform 
Chart. In Figure 5.67, the configuration display for the Tone Measurement function is displayed with the 
settings used to measure frequency and plots of the signal before and after the function is applied. 
 
Figure 5.5: Tone measurements output frequency 
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Figure 5.6: Configure tone measurements parameters 
5.4.4 Pulse Rate Calculation 
The PR calculation is the maximum average frequency of the infrared AC signals around 1.5 Hz with a 
±50% search. The highest peaks can be assumed to be the PR because the raw graph of the AC signal, 
while having has some noise, is mostly representative of a clean PPG of the PR. The signal to noise ratio 
is very high resulting in the maximum average frequency measured being the PR.  
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Figure 5.7: Functions used to calculate pulse rate 
 
5.4.5 Spectral Measurements 
Both the DC components of the red and infrared signals were averaged using the Amplitude and Level 
Measurement function and had these averages displayed with numeric indicators. This is necessary 
because to use the DC components of the signals, they need to be quantified into a signal value to be used 
in the SpO2 calculation. 
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Figure 5.8: Amplitude and level measurements functions with numeric indicators 
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Figure 5.9: Configure amplitude and level measurements set to mean (DC) 
5.4.6 SpO2 Calculation 
As mentioned previously, the SpO2 calculation, with A = 110 and B = -25, is:  
   (
(
  
  
)
   
(
  
  
)
  
)                                                                  (4) 
To create this equation in LabVIEW, the divide, add, and multiply functions were used on the already 
processed AC and DC components of the red and infrared signals.  At the end of the configuration of 
functions used to create the SpO2 equation in LabVIEW, which can be seen in Figure 5.11, there is a 
numerical indicator and waveform chart so that the ratio (
(
  
  
)
   
(
  
  
)
  
)  is displayed on the Front Panel and 
monitored to ensure that this section of the VI is working. 
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Figure 5.10: SpO2 calculation 
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5.4.6.1 Limiting Range of SpO2 Measurement 
To receive the desired measurement range of 0-100 for SpO2, the SpO2 equation is first normalized by 
dividing the value produced by the SpO2 equation by 110 and multiplying by 100. This value is then 
passed through a simple logic test. The logic test states if the value is greater than 0 and less than 100 it 
will be displayed on the SpO2 gauge and waveform chart. Otherwise, the value is multiplied by 0 and then 
displayed on the SpO2 gauge and waveform chart. 
 
 
Figure 5.11: The configuration of function that limit the displayed SpO2 
Below are images of the block diagram and front panel of the full VI used in this project. 
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Figure 5.12: VI Block Diagram 
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Figure 5.13: VI Front Panel 
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5.4.7 Preliminary VI Test 
To test the VI, four digitally simulated signals were used with a control, a function in LabVIEW that will 
allow the manipulation of a variable while the VI is running, was placed on the amplitude of the red AC 
signal. This control was used to manually increase the red AC signal’s amplitude causing the SpO2 to 
decrease. This test of the VI replicated the oxygen decrease in the blood of a person who was hypoxic.  
Below are images that demonstrate the success of this preliminary test of the VI. Figure 5.15, 
depicts the VI at the start of the test with the amplitude control at 0.5, the control can be seen below the 
SpO2 gage and to the left of the LabVIEW stop button.  Since the amplitude control has not been changed 
yet the SpO2 graph in the upper right of the figure is a straight line and the AC Red Input and Red AC 
Filtered graphs have the relatively large amplitudes of 20Hz. As the amplitude control is slowly increased 
to 21, the SpO2 graph in the upper right of Figure 5.16 shows a steady decrease and the AC Red Input and 
Red AC Filtered graphs now have amplitudes of 0.4Hz.  
The “R” indicator, which displays the ratio value calculated during the SpO2 calculation, is seen 
to increase between the two figures, as it was expected, because it is necessary for the ratio to increase for 
the resulting SpO2 to decrease. The other graphs and indicators do not show a change in between Figure 
5.15 and 5.16 because this was a controlled tested with simulated input signals. 
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Figure 5.14: Front panel for the simulated hypoxia test with low amplitude 
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Figure 5.15: Front panel for the simulated hypoxia test with high amplitude 
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Figure 5.16: Block diagram for the simulated hypoxia test
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 Experimentation/Testing 5.5
5.5.1.1 ECG and Reference Pulse Oximeter Reliability Test 
For measurement and comparison purposes a HOMEDICS Deluxe Pulse Oximeter with transmission 
method for the finger was utilized as a reference along with our pulse oximeter prototype. The reliability 
of the reference pulse oximeter was tested against an ECG Biopac module model 100C.  
Three ECG electrodes were connected to each subject’s right arm, left arm and left leg. Data 
collected from the ECG electrodes were displayed by the AcqKnowledge software and changes in PR 
were monitored on the screen using peak to peak analysis. The pulse oximeter was placed on the subject’s 
index finger. The ECG Biopac module was turned on and one minute of data were collected while the PR 
was monitored by the finger pulse oximeter at the same time. Accuracy and error percentages were 
calculated from each measurement. We calculated the error to be less than +3%, which matches the finger 
pulse oximeter’s specification sheet and deems it suitable to use as a reference. 
5.5.1.2 Wrist Measurements 
The probe of an oscilloscope was connected to the AC infrared outlet of the circuit and to common 
ground. The display of the oscilloscope was set up to segments of 500 milliseconds with amplitude of 2 
volts so the blood pressure wave was clearly visualized. Since the AC component of the infrared outlet 
from the circuit showed a more defined representation of the blood pressure curve than the AC red 
component, the AC infrared component was utilized as a second visual reference for the testing phase of 
the prototype. 
The sensor was strapped tightly to the wrist of the subject by means of a Velcro strap to maintain 
constant pressure while the subject was sitting with his/her arm resting on a table. Although we 
encouraged the subjects to place the sensor directly over the radial artery, the specific location and 
orientation of the sensor varied for each individual since PPG intensity can vary from person to person.  
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Figure 5.17: Application of the sensor to the wrist (left) and the chest (right) 
The VI is setup to collect data in ten seconds intervals during six minutes. Measurements from 
the reference pulse oximeter, which was worn on the subject’s finger, were taken at the same time that a 
new measurement appeared on our prototype VI. These results were recorded in an excel spreadsheet for 
the corresponding time. Measurants were recorded using the described procedure while sitting and 
standing.  
5.5.1.3 Chest Measurements 
The sensor was then attached to the chest using a longer Velcro strap and positioned directly over the 
sternum to obtain a strong PPG signal. The oscilloscope was set again with a window of 500 milliseconds 
and amplitude of 2 Volts. The pressure applied to the sensor on the chest varies depending on the 
subject’s ability to display a continuous PR wave on the oscilloscope and their comfort level.  The chest 
test was performed while the subjects were sitting and standing over six minutes. 
5.5.1.4 Hypoxia Testing 
The ability of the prototype to reproduce accurate low SpO2 levels was also tested. Here, the sensor was 
strapped around the wrist and data were collected right after asking the subject to self-induce hypoxia by 
not breathing for 45 seconds. Hypoxia test were performed on four different sitting individuals. Only one 
individual was able to show a drop in SpO2 levels after 45 seconds. The lowest SpO2 value observed on 
the reference pulse oximeter was 91% while the VI displayed a value of 93%. 
5.5.1.5 Hyperventilation Testing 
The final test performed was a hyperventilation test in which we measured how well our prototype 
responding the changing values of PR. During this test four different subjects were asked to strap the 
sensor to the wrist and remain calm with their arm extended and relaxed on a table with the reference 
device attached to the finger. The subjects were asking to breathe normally for a 1-minute period to obtain 
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a stable PR. After the initial minute, each subject was then asked to begin hyperventilating for about 4 
minutes. After the hyperventilation period the subjects were asked to breathe normally again for an 
additional minute to conclude the 6 min test and to show a declining PR. The results were compared to 
the reference device and plotted data were produced and shown in the results section. 
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6 Final Design 
 Device Hardware 6.1
For our final design, we took alternative design 1 and modified parts of it for efficiency. For the sensor 
block we increased the number of photodiodes surrounding the LEDs in order to obtain a lower degree of 
sensitivity that would otherwise be present with a smaller amount of photodiodes. More photodiodes also 
results in an increase in the total photodiode surface area which can capture reflected light. 
6.1.1 Sensor 
The design for the sensor module was based on the need for a concentric photodiode arrangement around 
two LEDs, one infrared and one red. Since that a larger number of photodiodes would only benefit the 
device, the group decided to utilize 8 surface photodiodes instead of the 4 that was designated in 
alternative design 1. In Figure 6.1 Figure 6.1 below, we can see the top view of the sensor module that 
the group developed. The red and infrared LEDs are placed in the center of 8 photodiodes which are able 
to pick up light from nearly every angle. The added effect of the photodiodes is also a benefit since 
summing up the current from all eight photodiodes maximizes the fraction of total backscattered light 
collected by the sensor. 
 
 
 
Figure 6.1: Top View of sensor module with photodiodes and LEDs. 
The placement of the LEDs relative to the photodiodes was also important. Since the LEDs were 
much larger than the photodiodes, we had to consider how we could design the sensor so that the LEDs 
and photodiodes were the same level when placed on the skin. Our solution for this was using a two 
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platform design. In Figure 6.2Figure 6.2, we present a side view image of our sensor module with each 
platform labeled. 
 
Figure 6.2: Platform view of sensor module 
The top platform, which is the surface of the device that is placed against the skin, was used 
primarily for the placement of the photodiodes. A rectangular opening was then made in the center of the 
board to allow for the LEDs placed on the bottom platform to protrude through and allow the light to pass 
through the skin. To allow for portability and to reduce the weight of the sensor, we separated the sensor 
module from the actual circuitry and connected 4 wires from the sensor to the circuitry board.   
6.1.2 Circuitry 
To process the signals obtained from the sensor module, we implemented several different signal 
processing techniques which helped to simplify the programming required in the VI. The block diagram 
in Figure 6.3Figure 6.3 shows a simplified view of our circuitry and how it is connected. 
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Figure 6.3: Block diagram of the prototype pulse oximeter 
The LEDs in the sensor module are driven at alternating frequencies of 100Hz with a 2.5ms delay 
between each LED as it is turned on. Figure 6.4 displays the timing diagram of the Arduino 
Microcontroller which is used as an LED driver. The board was programmed so that the first channel (in 
yellow) is ON for 2.5ms and OFF for 7.5ms while the second channel (in green) is OFF for 5ms, ON for 
2.5ms and then OFF for 2.5ms. 
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Figure 6.4:LED driver timing diagram with 2.5ms time increments 
For the photodiodes, we used an op-amp in photovoltaic mode so that the current output of the 
photodiodes is converted to a voltage. The voltage, which is directly related to the amount of light 
collected, is then sent through two Sample-and-Hold ICs (LF398) (S/H) to separate the red and infrared 
signals. To accomplish this, the voltage output by the photodiodes were connected simultaneously 
connected to both S/H and used the LED driver signals for the red and infrared LEDs as the logic driver 
for each S/H respectively.  Each S/H is  able to sample the respective LED to which they are connected to 
and hold that value until the next time the LED is turned on. The output of each S/H provided the AC and 
DC components of the PPG required for calculating oxygen saturation. However, because the AC 
component is generally very tiny compared to the DC component, it was necessary to filter this signal 
further so that the DC component can be removed and the AC component is amplified. The circuit in 
Figure 6.55 Figure 6.5a detailed diagram for each signal processing stage in the block diagram. 
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Figure 6.5: Circuit design for pulse oximeter device 
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To filter and separate the AC component from the AC and DC components, obtained from the 
S/H, each respective signal red and infrared was processed through a 2
nd
 order bandpass filter. Both 
bandpass filters were designed with a frequency cutoff of 1.5Hz and bandwidth of 1.5Hz. The rationale 
behind the selected characteristics is that a range between 0.75Hz and 2.25Hz should be enough to 
capture and amplify the signals of almost any individual who is at rest. Although the ideal use for any 
pulse oximeter is to work efficiently at rest and in motion, we felt for the purpose of this project this 
frequency range would be enough to prove a concept and provide accurate enough readings for 
individuals with PR between 45bpm and 135bpm. 
Seeing a lot of high frequency noise riding on top of a DC offset present in the red signal, we then 
implemented an additional high pass and low pass filter for the red AC signal so that the DC offset could 
first be removed and then second so that the high frequency noise could also be filtered out. The last stage 
in the signal processing is the amplification of the respective red and infrared AC signals at which point 
they are ready to be interfaced with the DAQ and processed by the VI. 
 Software  6.2
The final design of the block diagram and front panel of the VI can be seen below. The VI starts by 
accessing the signals from the sensor with the DAQ Assistant and then separating the signals by 
implementing select signals. Once the signals are separated and identified the AC components of the red 
and infrared signals are measured using the peak-to-peak method while the DC components were 
measured by finding their respective averages. The peak-to-peak method was chosen for the AC 
components because it is a straightforward measurement which can be compared to the readings of an 
oscilloscope.  Averaging the DC components was necessary because it provided a single value to be used 
in the SpO2 calculation for each data set sampled.  
Once the signals are processed SpO2 can be calculated as the ratio of the red AC/DC divided by 
the infrared AC/DC multiplied by -25 and added to 110. To provide a SpO2 measurement between 0 and 
100, the SpO2 calculation is then divided by110 and multiplied by 100 so that the value is normalized. To 
calculate the PR, the frequency of the AC infrared signal was measured using the tone measurements 
function and then multiplied by 60 to calculate the PR in beats per minute.  
Since the VI is constantly sampling data as long as the sensor and a power supply is connected to 
it, the VI samples noise and runs the computations for PR and SpO2 even if the sensor is not being worn. 
To avoid this, case structures were used to introduce thresholds which allow the VI to calculate 
measurements when the amplitude of the red and IR AC signals were above a certain level and to output 0 
when these conditions were not met.  
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Figure 6.6: Block Diagram of Final VI 
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Figure 6.7: Front Panel of Final VI
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7 Results 
The VI was set to collect and average data every 10 seconds throughout a 6 minute timespan accounting 
for 36 measurements per data set. The VI was programmed to output SpO
2 and PR every 10 seconds at 
which point a second individual that was monitoring the control device recorded the corresponding SpO
2 
and PR values displayed by the HOMEDICS pulse oximeter. Subjects were tested while sitting, standing, 
hyperventilating, and during self-induced hypoxia. PPG readings were acquired from both the chest and 
wrist. Each subject was asked to hyperventilate to mimic an increase in pulse rate and each of the subjects 
was also asked to hold their breath for 30 to 40 seconds after a full exhale to induce hypoxia. These tests 
showed the devices ability to detect increasing and decreasing levels of PR and SpO2 respectively. To 
compare the accuracy of our prototype to that of the reference pulse oximeter we calculated the average 
SpO2 and PR for each data set, and then calculated the percent error using the accuracy equation below 
summarized in Table 7.1. 
                  
                 
       
                                          ( )        
 
Table 7.1: Calculated accuracy for the average SpO2 and PR for each data set 
Average 
Measurements 
Reference Prototype Percent Errors 
SpO2 (%) PR (bpm) SpO2 (%) PR (bpm) SpO2 PR 
Wrist 
Standing 
97.9 92.6 97.3 92.8 0.6 0.2 
Wrist Sitting 98.2 82.4 98.4 83.3 0.2 1.1 
Chest 
Standing 
98.1 96.7 98.5 96.5 0.4 0.1 
Chest Sitting 97.8 83.8 98.1 83.9 0.3 0.1 
 
This method was only used for the standing and sitting positions for both chest and wrist 
readings. To calculate the percent error for all the data collected with our prototype, we first used the 
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accuracy equation on every individual measurement taken for each data set and averaged the percent error 
per measurement. To calculate the prototype’s accuracy, we then averaged the percent error for each data 
set to obtain a single value. The accuracy of each data set and the prototype’s final accuracy are shown in 
Table 7.2. Due to the fact that we were focusing primarily on SpO2 for hypoxia and PR for 
hyperventilation, we chose to collect only those measurants during our testing and did not take 
measurements for PR and SpO2 respectively. 
 
Table 7.2: Prototype accuracy based on all data collected 
Measurement Position 
Accuracy (Percent Error %) 
SpO2 PR 
Chest 
Sitting 0.76 3.15 
Standing 0.60 3.09 
Wrist 
Sitting 0.24 4.14 
Standing 0.76 3.75 
Hypoxia 
 
1.50 
 
Hyperventilation 
  
5.32 
Prototype Accuracy 0.77 3.89 
 
 As seen in a couple of the graphs in the sections below, there were examples of outliers in some 
of the data. These outliers were linked to a corrupted PPG signal in which the PPG was somehow affected 
by factors such as motion artifact or inconsistent pressure. Figure 7.1 shows an example of a corrupted 
PPG, in turn compromising the accuracy of that data point.  
 
Figure 7.1: Example of corrupted PPG 
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 Comparison Graphs 7.1
Comparison graphs are a useful tool when graphically representing our data because it enables to compare 
all the data sets for the prototype and reference devices for one test as a whole. Figure 7.2 displays a 
regression line for the PR data collected from our pulse oximeter prototype on the chest of four different 
subjects over a six-minute period while sitting.  The data are clustered in four different groups, each one 
having a distinctive symbol corresponding to the subject tested. The total PR data obtained from our 
prototype for all four subjects ranges from 55 to approximately 105 bpm. The linear regression equation 
obtained from the data points as well as the statistical coefficient R
2 
that determines how well the 
regression line approximates a linear trend are shown on the upper left corner of the graph. Table 7.1 
shows that the PR measurements taken from the chest while sitting has a low percent error of less than 
1% when looking at the average of the data and 3% when calculating the accuracy of each individual data 
point.    
The fact that R
2
 is close to 1 and the slope of the regression line is also very close to 1 show that 
the measurements picked up by the prototype appear to be well correlated with the measurements picked 
up by the reference pulse oximeter. This can also be observed visually by looking at how closely the 
regression line is to the line of identity. 
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Figure 7.2: Comparison graph for the chest sitting tests. The solid line represents the regression line and the dashed line represents the identity line. 
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In Figure 7.3, a comparison plot referencing the data collected from our prototype on the chest of 
four different subjects while standing over a six minute period is displayed. The measuring scale ranges 
from 80 to 120 bpm with increments of 5 bpm.  The linear regression equation and best fit coefficient are 
shown at the upper left corner. Similar to the regression line presented in Figure 7.2, the regression line in 
this comparison graph shows a slope very close to 1. The statistical coefficient of determination R
2
, which 
is used in the context of statistical modeling for predictions, is a measure of how good a predicted value 
might be construed from the modeled values. A lower R
2
 also shows that the correlation coefficient 
denoted as R, is lower than the sitting measurement shown in Figure 7.2. 
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Figure 7.3: Comparison graph for the chest standing tests. The solid line represents the regression line and the dashed line represents the identity line. 
80
85
90
95
100
105
110
115
120
80 85 90 95 100 105 110 115 120
P
ro
to
ty
p
e
 P
R
 
Reference PR 
Subject 1
Subject 2
Subject 3
Subject 4
y = 0.93x + 6.31 
R² = 0.70 
 65 
Figure 7.4 displays a regression line for the PR data collected from our pulse oximeter prototype 
on the wrist against the HOMEDICS reference finger pulse oximeter on four different subjects over a six 
minute period while sitting.  The data are clustered in four different groups, each one having a distinctive 
symbol corresponding to the subject tested. The measuring scale ranges from 50 to 120 bpm with 
increments of 10 bpm. The total PR data obtained from our prototype for all four subjects ranged from 52 
to approximately 105 bpm. The graph displays the linear regression line and R
2 
on the upper left corner. 
In this set of data we observed that the coefficient of variance, R
2
, and in turn the coefficient of 
correlation, R, to be slightly lower than the values observed from the chest while sitting. When visually 
comparing the regression line to the line of identity, we can conclude that these measurements were not as 
accurate compared to the reference pulse oximeter. 
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Figure 7.4: Comparison graph for the wrist sitting tests. The solid line represents the regression line and the dashed line represents the identity line. 
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In Figure 7.5 a comparison plot referencing the data collected from our prototype on the wrist of 
four different subjects over a six minute period while standing is displayed. The measuring scale ranges 
from 60 to 120 bpm with increments of 10 bpm.  The linear regression equation and best fit coefficient 
are shown on the upper left corner. When comparing the standing wrist measurements to the sitting wrist 
measurements shown in Figure 7.4, we saw that the measurements obtained from the wrist while standing 
appeared to be the least correlated data set. Visually, there appears to be more variations between the 
identity line and the regression line than in other comparison graphs. 
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Figure 7.5: Comparison graph for the wrist standing tests. The solid line represents the regression line and the dashed line represents the identity line.  
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The plot displayed on Figure 7.6 shows the data points collected from our prototype on the wrist 
of four different subjects over a six minute period with the HOMEDICS reference device attached to the 
finger while hyperventilating. The measuring scale ranges from 50 to 140 bpm with increments of 10 
bpm.  The linear regression equation and best fit coefficient are shown at the upper left corner. One 
characteristic that is quickly observed when looking at this graph is that there is a lower accuracy in these 
measurements than in the previous graphs. This is visible in how the data points are distributed and the 
distance between points. Another aspect of these graphs that was noticed was that there appeared to be 
more outliers present in the data than in the other data sets. 
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Figure 7.6: Comparison graph for hyperventilation tests 
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The hypoxia testing graph shown in Figure 7.7 was performed on 2 subjects capable of holding 
their breath for more than 40 seconds. SpO2 readings were collected by our prototype pulse oximeter as 
well as by the reference HOMEDICS device. The measuring percentage scale ranged from 90 to 100 with 
increments of 1%. Regression line equation and best fit line coefficient are given at the upper left corner. 
For the purpose of plotting a regression line for SpO2 we found it very difficult to correctly plot a 
regression line when the data had only a 10% range. Considering that for the majority of testing the 
subjects maintained a SpO2 level of 97 or 98% we were only able to measure several small dips to assess 
the responsiveness of our device to changing SpO2 levels. To correctly plot a regression line, one would 
need to change the SpO2 levels over a larger range such as 70-100% in order to have a better idea of how 
well our device compares to the reference pulse oximeter. 
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Figure 7.7: Comparison graph for hypoxia tests. The solid line represents the regression line and the dashed line represents the identity line. 
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 Dynamic Response Plots 7.2
 
Dynamic response plots were utilized in analyzing the data because they show the prototype’s response to 
changing levels of PR and SpO2 over time. These plots in particular were utilized for all of the 
measurements to better understand how our device reacts to varying PR. The fact that the SpO2 levels 
varied very little in most of the measurements doesn’t provide any real indication as to whether the 
prototype is able to response to changing levels of SpO2. To address this, we performed hypoxia tests in 
which we saw the SpO2 level drop to around 90 and plotted those results. 
Figures 7.8 and 7.9 depict the SpO2 and PR measurements during the 6 minute testing period 
respectively. Although the only information we can obtain from Figure 7.8 is that the SpO2 remained 
constant throughout the entire measurement, Figure 7.9 shows the prototypes response to changing levels 
of PR. One feature that was observed was that at times when the PR would ramp up, the prototype would 
instead ramp downwards towards a smaller PR. In fact, it was observed that this occurred 5 times during 
the measurement period. 
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Figure 7.8: Oxygen saturation measurement validation plot for the chest standing test 
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Figure 7.9: Pulse rate measurement validation plot for the chest standing test 
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Figures 7.10 and 7.11 display the dynamic response plots for the chest measurements of one 
subject while sitting.  Although it was observed that the prototype’s measurements bounced around 98% 
and 99%, this still doesn’t give us any real interpretations as to how the prototype can handle different 
values of SpO2. Figure 7.11 displays the changing PR measurements over time, depicts the variations in 
PR of an individual at rest. We did notice from this chart that while our prototype appeared to be 
following the general trend of data and PR variability, there was indeed quite a number of errors in the 
measurements. Some cases of overshooting and undershooting were observed as well as certain data 
points which appeared to almost be delayed PR values of the reference pulse oximeter.   
 77 
 
Figure 7.10: Oxygen saturation measurement validation plot for the chest sitting test
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Figure 7.11: Pulse rate measurement validation plot for the chest sitting test 
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Figures 7.12 and 7.13 display the dynamic response plots for the hyperventilation trials. Both 
figures display varying PR’s for two subjects during the 6 minute measurement period. Plot 1, depicted as 
Figure 7.12 shows a very high correlation between the prototype and the reference pulse oximeter. This is 
evident in the proximity of the data points between the prototype and reference pulse oximeter as well as 
the general trend that the chart follows. However, it was noticed that at 80 seconds, there was an 
unexplained drop in PR from the 75-80 range to a PR value of 53. The reason for this was believed to be 
due to corrupted PPG signals during that 10 second duration of measurements. Figure 7.1 shows how a 
corrupted PPG signal appears. Since our method for calculating PR is by searching for the highest 
amplitude around a specific frequency, any high frequency noise presented either through ambient light 
picked up by the sensor or by motion artifacts would slant the power spectrum of the signal which in turn 
would provide false PR calculations for that interval of data. Figure 7.13 shows similar drops in PR as 
well due to corrupted PPG signals. One difference observed in Figure 7.13 was that the data were not as 
closely correlated as in Figure 7.12. 
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Figure 7.12: Pulse rate measurement validation plot 1 for hyperventilation test  
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Figure 7.13: Pulse rate measurement validation plot 2 for hyperventilation test 
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Figures 7.14 and 7.15 depict the PR and SpO2 measurements during the 6 minute testing period 
from the wrist as the subject was sitting, respectively. Figure 7.14 shows the prototypes response to 
changing levels of PR. In general this set of data appears to be very closely correlated and only contains 
one measurement in which the PR overshoots the reference by about 4bpm. In Figure 7.15 we can 
observe a small dip at the beginning of the measurements in the SpO2 but otherwise, the SpO2 levels 
stayed constant throughout the entire measurement. 
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Figure 7.14: Pulse rate measurement validation plot for the wrist sitting test 
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Figure 7.15: Oxygen saturation measurement validation plot for the wrist sitting test 
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Figures 7.16 and 7.17 depict the SpO2 and PR measurements during the 6 minute testing period 
from the wrist as the subject was standing. In Figure 7.16 we observe a constant bouncing of SpO2 
between 98 and 99% for our prototype and a dip in SpO2 at around 2 minutes into the measurements. 
Figure 7.17 shows the prototypes response to changing levels of PR while the subject was standing. Apart 
from two moments of undershooting in which the value displayed on the prototype was lower than the 
value displayed on the reference device, the rest of the data appeared to be slightly less well correlated 
than when the subject was sitting.  
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Figure 7.16: Oxygen saturation measurement validation plot for the wrist standing test  
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Figure 7.17: Pulse rate measurement validation plot for the wrist standing test 
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To accurately see how well our device responded to sudden drops in SpO2 we asked our subjects 
to hold their breaths for 45 seconds in hopes that a drop in SpO2 could be observed. Figures 7.18 and 7.19 
display two separate plots for induced hypoxia. In Figure 7.18 the moment of induced hypoxia can be 
observed at around 120-160 seconds in which the SpO2 dropped from 99 to 91% in the reference pulse 
oximeter and 97 to 93% for the prototype. While the drop in SpO2 for the prototype was not as sudden as 
it was for the reference pulse oximeter, it does in fact validate the claim that our prototype does respond 
to changing levels of SpO2. In Figure 7.19 we observe two moments of induced hypoxia, once at 150 
seconds and later at 230 seconds. We also observed what appeared to be a delay between our prototype 
and the reference pulse oximeter when the drops in SpO2 occurred. 
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Figure 7.18: Oxygen saturation measurement validation plot 1 for hypoxia test 
90
91
92
93
94
95
96
97
98
99
100
0 50 100 150 200 250
S
p
O
2
 (
%
) 
Time (Sec) 
Reference
Prototype
 90 
 
Figure 7.19: Oxygen saturation measurement validation plot 2 for hypoxia test 
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 Residual Plots 7.3
Residual plots were also utilized in analyzing the hypoxia and hyperventilation tests. To graph the 
residual plots, we calculated the average between the observed measurements from the reference device 
and our prototype, the difference between each observed measurement, the average of the difference 
between each observed measurement number, and the standard deviation of the differences. Using these 
calculations we then plotted the averages of the individual measurements on the horizontal axis and the 
difference between measurements on the vertical axis. A solid black line was then plotted to represent the 
average of the differences, and two dashed black lines to represent + 2 standard deviations around the 
average of the difference of measurements. Figures 7.20, 7.21 and 7.22 show the residual plots for the 
hyperventilation testing. All of these plots show that at least 95% of the data falls within the two standard 
deviations meaning that the differences between the reference device and the prototype are normally 
distributed. Although 95% of the data in each figure does fall within the two standard deviations, Figure 
7.22 shows the best representation of a high correlation between the reference device and the prototype. 
Most of the data shown in that plot is much closer to the average of the differences, shown as the black 
solid line.  
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Figure 7.20: Residual plot for hyperventilation testing for data set 1 (dotted lines: + 2SD, solid line: average of differences) 
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Figure 7.21: Residual plot for hyperventilation testing for data set 2(dotted lines: + 2SD, solid line: average of differences) 
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Figure 7.22: Residual plot for hyperventilation testing for data set 3 (dotted lines: + 2SD, solid line: average of differences)
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Figures 7.23 and 7.24 show the residual plots for the hypoxia testing. The data in both plots 
appear to be slanted to one side due to there not being a large enough SpO2 range to effectively measure. 
However, one positive to note from these plots is that the majority of the residuals in both plots appear to 
fall within two standard deviations of the average difference. 
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Figure 7.23: Residual plot for hypoxia testing for data set 1 (dotted lines: + 2SD, solid line: average of differences) 
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Figure 7.24: Residual plot for hypoxia testing for data set 2 (dotted lines: + 2SD, solid line: average of differences)
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8 Discussion 
When creating a device such as a pulse oximeter which requires the acquisition of signals such as PPGs, it 
is difficult to ensure the integrity of the signals that are acquired. This causes the placement of the sensor 
on the wrist and chest to be very important. We were able to obtain fairly strong PPGs from the wrist and 
chest because of the stronger signals due to the high levels of bone and subcutaneous tissues in these 
locations.      
The summarized results suggest that recorded wrist measurements were more accurate than chest 
measurements. For the standing and sitting measurement tests obtained from the wrist, the errors obtained 
were 0.6%, and 0.2% for SpO2 and 0.2%, 1.1% for the PR, respectively. While the measurements from 
the chest obtained errors of 0.4% and 0.3% for SpO2 and 0.1%, and 0.7% for the PR, respectively for the 
same test conditions. There are many factors that could contribute to the difference in the percent errors 
for the two different locations. When the sensor was placed on the wrist, it was placed over the radial 
artery which could have given stronger signals as opposed to those gathered from the chest where the 
sensor was simply placed over the sternum. One factor noticed was when the sensor is placed on the 
chest, the device became subject to increased motion artifact from breathing. The motion the chest makes 
when each subject took a breath in some cases moved the device on the skin and could have also 
prevented it from being in constant contact with the skin. Another factor that could have affected this is 
the pressure at which the device was strapped on. If there was too much or too little pressure, the signal 
strength could change, in turn changing the results. For this device to be considered a success, the percent 
error for all tests must remain at ±3. Although these factors did not affect the accuracy of the device in an 
extremely negative way as displayed in the results, they were cause for a slightly higher percent error in 
data taken from the chest. In these cases it was noticed the sensor would allow ambient light to be picked 
up by the photodetectors. It was observed that when this occurred, the sensor output would completely 
saturate due to the high amplification we utilized for signal analysis. 
The standard tests of standing and sitting while taking measurements from the chest and wrist 
showed that the prototype could accurately and continuously measure SpO2 and PR. While the hypoxia 
and hyperventilation tests demonstrated that the prototype can respond to various SpO2 and PR 
measurements respectively. The comparison graphs were used to plot each set of data for each test on one 
graph together. In these graphs, the reference device was plotted against our prototype to see the 
correlation between the two. Each different marker corresponds to a different subjects’ data taken. The 
identity line represents a line with a slope of 1. This was useful to plot in the comparison charts because it 
represents the slope our data is expected to follow when comparing devices as such. The regression line in 
these plots models the relationship between the reference device and our prototype. In figures 7.2 and 7.3 
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displaying PR data, the regression line has a slope of .93 and .93 respectively. These slopes show the high 
correlation between the reference device and our prototype for both the chest sitting and standing results 
when measuring PR. In figures 7.4 and 7.5 displaying PR data, the regression lines have a slope of .89 
and .73 respectively, also showing a high correlation between the reference device and our prototype for 
the wrist sitting and standing when measuring PR. When testing the devices ability to detect changing PR 
and SpO2, the group only took measurements from the wrist. This was decided because of the increased 
accuracy in the measurements taken from the wrist. Figure 7.6 displays the PR data for the 
hyperventilation testing. The slope of the regression line here is .88 showing that our device is able to 
accurately detect changes in PR that would mimic those of exercise. Figure 7.7 displays the SpO2 data for 
hypoxia testing. The slope of the regression line here is .33 which would normally indicate that the device 
does not have a high correlation with the reference device however, because SpO2’s measurements are on 
such a small scale, even the slightest of discrepancies would cause a big change in the slope of the 
regression line. It is for examples like this that it was necessary to analyze the data in more than one way 
and to have more than one form of graphical representation.  
The dynamic response plots were used to see the prototypes response to PR and SpO2 as opposed 
to the reference devices response over time. Each graph contains a line representing the prototype and a 
line representing the reference device. While the plots here for the chest while sitting and standing and the 
wrist while sitting and standing show that the measurements from our prototype remain in close proximity 
to those of the reference device, the most valuable plots are those done for hyperventilation and hypoxia. 
Figures 7.12 and 7.13 show that the prototype can react to changing levels of PR as fast as the reference 
device does and with high accuracy. In figure 7.12 at about 75 seconds in and in figure 7.13 at about 250 
seconds there are noticeable outliers in the PR measurement from the prototype. The outliers for each 
subject went from a regular PR, around 90bpm, to values of about 40 or 50bpm. To verify whether this 
was due to abnormal PPG data or the software, the PPG data gathered by the VI was re-examined for the 
specific periods of time in which the outliers occurred. It was discovered that these outliers were 
primarily due to corrupted PPG data. Figure 7.1 shows a portion of the PPG data with corrupted readings 
which could be due to motion artifacts introduced by the subject through sudden movements. Another 
possibility for the corrupted data could be related to the amount of pressure applied to the sensor when it 
was placed on the subject. Figure 7.18 shows one drop in SpO2 during induced hypoxia at about 150 
seconds while figure 7.19 shows two drops in SpO2 during induced hypoxia at 160 seconds and at 230 
seconds. Both the prototype and the reference oximeter registered the drops in oxygen saturation, though 
the drop observed by our prototype was less than that of the reference device. This test demonstrated the 
prototype’s ability to detect a decrease in SpO2 with some degree of accuracy.  
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 Residual plots were used to show by how much the prototype is likely to differ from the reference 
device. These plots allow us to see if there are any large discrepancies between the reference device and 
the prototype that would otherwise not be seen in the comparison charts. Figure 7.22 shows one of the 
residual plots for hyperventilation testing. In this plot we can see that there is not a large difference in the 
data gathered from the reference device and the prototype as all the data is fairly close to 0 and well 
within the 2 standard deviation limits showing that our data is normally distributed. Figures 7.20 and 7.21 
show the remaining two residual plots for hyperventilation. These two plots show a much larger range of 
difference between the reference device and the prototype however, 95% of the values are within the 2 
standard deviation limits and that the data is normally distributed as well. Figures 7.23 and 7.24 show the 
residual plots for hypoxia testing. These two plots show that the differences between the reference device 
and the prototype are very small ranging from a difference of either 1 or 2 and shows that 95% of these 
data points are also within the 2 standard deviation limit showing that our data is normally distributed.     
From the data presented in Table 7.2, the accuracy of the PR measurements ranged in percent 
error between 3-5% for every single data set. From this it was concluded that while the tone 
measurements function in LabVIEW is a simple and effective method for calculated PR, it introduces a 
high degree of error since it is programmed to seek the highest amplitude frequency. For SpO2 a low 
percent error was maintained for all the stationary measurements, but there was a decrease in accuracy 
when the prototype was experiencing changing SpO2 levels. To ascertain a more precise accuracy for the 
prototype, further testing should be done in which the SpO2 levels range from 70-100%. 
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10 Summary 
 
This project started with the goal of designing and building a wearable reflectance-based pulse oximeter 
that could measure SpO2 and PR accurately from the chest and wrist. A literature search was the 
conducted exploring pulse oximetry theory, application methods, and commercial products. After which, 
alternative designs for a reflectance-based pulse oximeter were considered. Assessing the benefits of each 
alternative design, a design consisting of 8 photodiodes positioned concentrically around 2 LEDs, one red 
and one infrared at wavelengths of 660nm and 940nm, respectively, was selected. In the circuitry, an 
Arduino Duo microprocessor was used as the LED driver and the logic driver. Sample-and-Hold circuits 
were utilized to separate the appropriate signals for red and infrared light with analog bandpass filters 
implemented to isolate the AC component of the PPG waveforms from the DC component. Stages of 
operational amplifiers were also used to amplify the original signal created by the sensor and amplify the 
AC signals which were representative of the PPG fluctuations.    
The software for this project was developed in the program LabVIEW to further filter the signals 
and calculate SpO2 and PR. For the calculation of PR, tone measurement function was used inside of 
LabVIEW which searches for the highest amplitude signal around a custom set frequency. Expecting the 
frequency of the range of PRs to lie between 1Hz and 3Hz, the function was set to search around 2Hz 
with a window of + 50%.  This method was very effective in calculating the PR frequency and chose to 
stay with it rather than opting for a peak to peak analysis. The PR frequency was then multiplied by 60 to 
have the final PR values in beats per minute. 
For the calculation of SpO2 several functions inside of LabVIEW were used to obtain these 
values. For the AC signals, a function called AC & DC estimator which effectively measured the 
amplitude of every single amplified PPG fluctuation and then averaged this amplitude over 10 seconds 
worth off PPG data. To obtain a DC value for both red and infrared signals, the amplitude and level 
measurements function was used to average 10 seconds worth of data and come up with a constant value 
for the DC. These methods were found to be satisfactory for calculating the red and infrared AC and DC 
values due to the small variation in the signal once placed on the skin of an individual. Variations in the 
signal were only noticeable if the sensor was moved or if the subject moved during testing. For 
calculating SpO2, equation 2 was used with variables A= 110 and B = -25. The value for SpO2 was then 
normalized so that it is out of 100% and then plotted on a chart as well as having a visual gauge as a 
reference with a range from 0-100% SpO2.  
Tests were performed using our prototype and a HOMEDICS Deluxe Pulse Oximeter as a 
reference. For the chest measurements, the sensor was placed directly over the sternum while for the wrist 
measurements the sensor was worn on the left arm over the radial artery. Depending on the signal 
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intensity for each subject there were variations in the specific location over the radial artery in which the 
sensor was placed on to collect measurements. The pressure of the sensor on the skin was adjusted using a 
Velcro strap which went around the wrist and chest. The testing performed allowed for the collection of 
measurements from the chest and wrist while sitting and standing. Tests of hypoxia and hyperventilation 
were also performed to observe the responds of the prototype to changing levels of SpO2 and PR. Many 
of the subjects had trouble holding their breaths for the allotted 45 seconds thus the lowest SpO2 levels 
observed were 91%. From the gradual increase and decrease of PR, the prototypes response to changing 
PRs was observed. The VI was set to sample at 25 samples per second for 250 samples each 
measurement. Every 10 seconds, the VI would display 10 seconds worth of PPG waveforms, as well as 
the calculated PR and SpO2 for the last 10 seconds. To maintain the same sampling rate as the prototype, 
the SpO2 was also sampled and PR values of the reference pulse oximeter every 10 seconds to coincide 
with the results picked up by the VI. 
Once all of the measurements were taken, the data were analyzed using several different 
techniques. The averages of each data set were taken for both measurants from which the accuracy of the 
prototype to that of the reference pulse oximeter was calculated and comparative graphs were created. 
Regression lines were also calculated and plotted for each set of measurements and compared to an 
identity line with a slope of 1 and a y-intercept of 0.  
The hypoxia and hyperventilation measurements demonstrated how the device would perform 
with changing SpO2 and PR levels. To this effect, dynamic response graphs were plotted for each 
measurement. For the hypoxia and hyperventilation tests, respective prototype and reference pulse 
oximeter SpO2 values over time were plotted. Induced hypoxia resulted in lowered levels of SpO2 and 
showing a similar response in both the prototype and the reference pulse oximeter. During 
hyperventilation, rising PR on each subject were observed with the prototype and reference pulse 
oximeter. Lastly, residual plots were also created for the hypoxia and hyperventilation tests to investigate 
how our device differs from the reference device. This was accomplished by calculating the difference 
between the prototype and reference pulse oximeter for each measurement.  
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11 Conclusion 
Based on the experimental results derived several conclusions can be drawn. Through the testing 
performed on the prototype pulse oximeter we observed that it is in fact possible to measure SpO2 and PR 
from the wrist and chest with a reasonable level of accuracy. The SpO2 measurement contained an error 
of less than +1% and the PR measurements less than +4%. However the prototype does still need some 
improvement to increase the accuracy of the PR. Though simple to implement, the algorithm currently 
being used in calculating PR did not provide the level of accuracy required for a FDA regulated 
commercial device.  
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12 Future Improvements 
While the hardware and software components of this project met the project goals in that they were able 
to measure PR and SpO2, there are several improvements we could make in the future for the device to 
meet industry standards. One aspect of the hardware construction which we never really tackled was 
designing a PCB model. For the purposes of our project it was simpler to use a breadboard since 
adjustments were constantly being made with the hardware components to test different settings and for 
troubleshooting. A factory fabricated PCB board would give us the possibility to start planning for 
portability and how the device could be attached to the patient. While our design for this project involved 
a separate module for the LED and photodiode sensor from the actual circuitry, it could be possible to 
integrate everything in one board once a PCB design is fabricated. A PCB design would allow us to use 
smaller components in the circuit and minimize the size of the sensor as well as the accompanying 
circuitry.  
Another future improvement which could be implemented is the use of a National Instruments 
LabVIEW embedded microcontroller. This would not only minimize the amount of components used in 
the circuitry but would also remove our prototypes dependency on being connected to a desktop PC 
running LabVIEW in order for the device to work. An embedded microcontroller would allow us to add 
an LCD display which could show both SpO2 and PR to the patient. Another benefit for using an 
embedded microcontroller would be that circuit designs such as the Sample-and-Hold and the bandpass 
filters would no longer be necessary as analog components since these functions can be programmed 
digitally in LabVIEW. 
The hardware casing should also be redesigned to be not only more aesthetically pleasing but also 
fully wireless so that it can be worn anywhere. Currently as it stands, our prototype is fairly bulky and 
requires a constant connection to a desktop PC. Weight is also an issue since the enclosure for our 
circuitry is an aluminum box with dimensions of 5” x 3” x 3”. We feel that with the development of a 
PCB design, the overall size requirement for the casing would also dramatically decrease. Another aspect 
of the casing we would like to see changed is using a hard polymer shell instead of an aluminum box. A 
plastic casing would be easier to design in any modeling software and would be more easily manufactured 
with the use of molding techniques. Current developments in 3D printers with plastics would also make a 
plastic casing an easier option for manufacturing.  
To make the device fully portable, wireless connectivity should be considered for future 
improvements. Wireless connectivity, whether through WIFI, Bluetooth or NFC would not only remove 
from the user the burden of having wires running through the body but would also provide easier access 
of SpO2 and PR measurements. Although battery consumption might be an issue, a wireless pulse 
oximeter would be more user friendly and increase mobility for the user. The possibility of being able to 
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display these measurements on any smartphone or other portable wireless devices is another advancement 
that could make this device increasingly valuable for patients and clinicians. 
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Appendix A: Description of LabVIEW  
Discussed below are the functions used in the construction of the program that was used in this study.  
 
While loop is a structure that allows for the continuous sampling of input signals and the application of 
the diagrams placed within it. 
 
 
Figure A.1: While loop 
When placed in the block diagram, the DAQ assistant launches creating a new task. The task was to 
identify the signal provided by the external DAQ and set sampling parameters.   The task can be edited by 
double-clicking the DAQ assistant. For continuous measurement a while loop should be placed around 
the DAQ assistant. 
 
 
Figure A.2: DAQ Assistant 
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Figure A.3: DAQ assistant task 
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Figure A.4: DAQ assistant task with open details 
Select signals accepts multiple signals as inputs and returns only the signals selected allowing the user to 
specify which signals to include in the output. 
 
 
Figure A.5: Select signals 
The filter function filters a signal using an infinite impulse response or finite impulse response filter 
which removes or attenuates unwanted frequencies from a signal using various standard filter types and 
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topologies continuously. In this instance the Chebyshev filter was used because Chebyshev filters 
minimize the error between the idealized and the actual filter characteristic over the range of the filter. 
 
Figure A.6: Filter function 
 
Figure A.7: Filter function parameters 
111 
 
The tone measurements function finds the signal with the highest amplitude or searches a specified 
frequency range to find the single tone with the highest amplitude and also can find the frequency and 
phase. In this instance, this function is used to find frequency. 
 
 
Figure A.8: Tone measurements function 
 
Figure A.9: Configuration of the tone measurements function 
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Amplitude and level measurements performs voltage measurements on a signal, such as an average of the 
DC component of the signal, the maximum peaks, and the mean level of one complete period of a 
periodic input signal. 
 
Figure A.10: Spectral measurement function 
 
Figure A.11: Configuration of the spectral measurements 
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The AC&DC estimator.vi applies the Hanning window, which separates most of the AC energy from the 
DC bin, allowing the estimation the AC and DC levels of the input signal. 
 
Figure A.12: AC & DC estimator.vi 
Divide computes the quotient of the inputs. 
 
Figure A.13: Division 
Round to nearest integer rounds the input to the nearest integer. If the value of the input is midway 
between two integers, the function returns the nearest even integer. 
 
Figure A.14: Round to nearest integer 
Multiply returns the product of the inputs. 
 
Figure A.15: Multiply 
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Add computes the sum of the inputs. 
 
Figure A.16: Add 
The greater than function returns TRUE if x is greater than y and returns FALSE if y is greater than x. 
 
Figure A.17: Greater than function 
The less than function returns TRUE if x is less than y and returns FALSE if y is greater than x.  
 
Figure A.18: Less than function 
The and function computes the logical AND, meaning if both inputs are TRUE, the function returns 
TRUE and otherwise it returns FALSE. 
 
Figure A.19: And function 
Case structure has multiple sub diagrams, or cases, with only one case executing when the structure 
executes. The execution can be controlled by wiring a value to the case structure which will determine 
which case to use.  
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Figure A.20: Case structure 
Above is the numeric indicator that displays values continuously. The image on the left represents the 
function in the block diagram while the image on the right represents the function in the front panel that 
displays the commuted values.  
 
Figure A.21: Numeric indicator (left: block diagram, right: front panel) 
The gauge indicator is a continuous numeric indicator. The image on the left represents the function in 
the block diagram while the image on the right represents the function in the front panel that displays the 
commuted values.  
 
Figure A.22: Gauge indicator (left: block diagram, right: front panel) 
 
Waveform graph is a graphic indicator that evenly plots sampled measurements. The image on the left 
represents the function in the block diagram while the image on the right represents the function in the 
front panel that graphs the commuted values. 
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Figure A.23: Waveform graph (left: block diagram, right: front panel) 
Waveform chart is a numeric indicator that plots data at a constant rate and maintains a history of the data. 
The image on the left represents the function in the block diagram while the image on the right represents 
the function in the front panel that graphically records the commuted values. 
 
Figure A.24: Waveform chart (left: block diagram, right: front panel) 
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Appendix B: Bill of Materials  
 
Item Vendor Part Number Quantity Price 
Photodiodes Allied Electronics BPW34 8 $18.80 
940nm Infrared LED Radioshack 276-143 1 $2.49 
660nm Red LED Radioshack 55050641 1 $1.44 
Round Fiberglass 
Copper Boards 
Radioshack 276-004 1 $5.49 
Bread Board Radioshack 276-003 1 $9.99 
LF398LN Mouser LF398N/NOPB 2 $3.08 
LM348 Quad Op-Amp 
Obtained from 
BME Lab 
 3 $1.99 
Velcro Strap Home Depot 90340 1 $9.27 
Aluminum Box 
Enclosure 
Radioshack 270-238 1 $3.49 
Double sided tape Home Depot 285189 1 $6.97 
Arduino Duo 
Microcontroller 
Radioshack 276-128 1 $29.99 
   SUM $93.00 
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Appendix C: Data Sets 
Table C.1: Sitting chest data set 
Subject 1 Sitting 
Chest 
  
Subject 2 Sitting 
Chest 
  
Subject 3 Sitting 
Chest 
  
Subject 4 Sitting 
Chest 
  Reference 
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
Reference  
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR 
98 62 99 65 98 94 98 93 97 92 99 88 98 80 96 92 
98 60 99 63 98 96 98 92 98 94 99 99 98 80 98 82 
98 59 99 60 98 94 99 91 97 90 96 92 98 83 98 85 
98 60 99 60 98 94 99 93 98 93 95 91 98 86 98 87 
98 61 99 61 98 93 99 92 98 94 95 94 98 87 98 88 
98 60 99 62 98 96 98 93 97 91 95 94 98 87 98 87 
98 60 99 64 98 94 98 95 97 93 96 93 98 87 98 86 
98 63 99 63 98 89 98 96 97 93 95 94 98 85 98 86 
98 64 99 63 98 93 98 93 97 91 95 93 98 87 98 85 
98 61 99 64 98 91 99 90 97 91 96 92 98 91 98 89 
98 65 99 63 98 87 99 88 98 96 96 94 98 87 98 88 
98 68 99 64 98 87 98 91 98 98 95 94 98 89 98 91 
98 65 99 68 98 88 98 88 97 96 94 94 98 91 98 87 
98 61 99 63 98 91 98 92 97 94 95 97 98 83 98 89 
98 58 99 61 98 87 98 85 97 99 95 62 98 87 98 88 
98 60 99 59 98 89 98 91 97 97 98 101 98 82 98 81 
98 60 99 60 98 91 99 89 97 96 97 97 98 87 98 83 
98 59 99 64 98 91 98 91 97 96 97 95 98 87 98 86 
98 58 99 60 98 91 98 93 97 96 98 98 98 85 98 84 
98 58 99 59 98 91 98 89 97 91 97 97 98 86 98 88 
98 60 99 58 98 89 99 89 97 91 97 96 98 88 99 89 
119 
 
98 63 99 61 98 91 99 90 97 93 98 93 98 91 98 90 
98 73 99 63 98 93 99 88 97 94 98 99 98 87 98 89 
98 72 99 71 98 93 99 90 97 96 98 96 98 87 98 90 
98 79 99 71 98 91 98 92 97 99 98 68 98 87 98 85 
98 70 99 81 98 91 99 92 97 96 99 103 98 86 98 85 
98 68 99 71 98 94 99 92 97 98 97 96 98 88 98 93 
98 63 99 65 98 91 98 91 97 99 97 100 98 83 99 86 
98 59 99 64 98 89 99 88 97 96 98 99 98 85 98 83 
98 58 99 60 98 87 98 86 97 98 98 97 98 87 99 85 
98 56 99 59 98 89 99 89 98 98 97 99 98 82 98 88 
98 56 99 56 98 89 98 92 98 94 98 95 98 80 99 84 
98 58 99 59 98 91 99 94 98 98 98 94 98 89 98 90 
98 60 99 59 98 88 98 89 97 99 99 99 98 86 98 87 
98 60 99 62 98 91 98 91 97 101 98 99 98 87 99 89 
98 62 99 61 98 91 98 91 97 104 99 101 98 89 98 91 
98 62 99 61 98 91 99 91 97 101 98 101 
    
    
98 96 98 94 97 98 99 99 
    
                 
Table C.2: Standing chest data set 
Subject 1 Standing 
Chest 
  
Subject 2 Standing 
Chest 
  
Subject 3 
Standing Chest 
  
Subject 4 Standing 
Chest 
  Reference 
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR 
98 96 99 101 98 96 96 93 98 91 99 87 98 98 98 98 
98 101 99 99 98 94 98 92 98 91 99 89 98 94 98 97 
98 101 99 106 98 98 98 89 98 87 98 92 98 100 97 103 
98 108 99 108 98 101 98 92 98 87 99 94 98 99 95 100 
120 
 
98 108 99 111 98 93 97 93 97 87 99 82 98 98 98 98 
98 104 99 107 98 94 99 92 98 87 99 87 98 96 98 97 
98 106 99 98 98 96 99 94 98 88 99 85 98 96 99 102 
98 108 99 109 98 91 99 93 98 91 99 87 98 99 98 104 
98 101 99 108 98 96 99 95 98 84 99 89 98 96 98 95 
98 106 99 105 98 96 99 93 97 84 98 92 98 98 98 100 
98 103 99 111 99 94 99 93 98 86 99 83 98 99 98 103 
98 106 99 100 99 91 99 94 98 87 99 88 98 99 98 101 
98 103 99 104 99 91 98 90 98 84 99 85 98 98 98 97 
98 105 99 107 98 91 99 92 98 87 98 86 98 94 99 95 
98 104 99 107 98 91 99 92 98 87 99 84 98 99 98 103 
98 103 99 104 98 89 99 93 98 86 98 90 98 101 98 101 
98 104 99 103 98 89 99 92 98 87 99 88 98 99 98 101 
98 101 99 102 99 88 99 89 98 87 98 87 98 96 98 99 
98 104 99 103 98 87 99 91 98 91 98 86 98 98 98 98 
98 106 99 108 99 88 99 91 98 87 98 92 98 101 98 103 
98 106 99 100 99 94 99 90 98 89 98 92 98 101 97 99 
98 108 99 100 99 93 98 92 98 91 98 90 98 98 98 92 
98 109 99 106 98 96 99 95 98 87 98 87 98 101 98 100 
98 101 99 104 99 96 98 92 98 89 98 87 98 101 97 103 
98 101 99 101 99 96 99 94 98 87 99 84 98 104 97 106 
98 101 99 104 99 96 99 88 98 87 98 85 98 105 98 107 
98 106 99 105 99 94 99 92 98 87 98 87 98 106 98 106 
98 101 99 105 99 93 99 98 98 89 98 88 98 106 98 107 
98 104 99 106 99 91 99 95 98 92 98 89 98 112 99 108 
98 112 99 105 99 93 99 92 98 91 98 89 98 96 97 99 
98 107 99 116 99 94 98 92 98 87 98 92 98 101 98 99 
98 104 99 110 99 91 99 94 98 89 98 91 98 101 98 102 
121 
 
98 108 99 107 99 94 99 94 98 89 98 90 98 104 98 106 
98 108 99 107 99 94 99 94 98 92 98 89 98 105 98 106 
98 109 99 105 99 93 99 69 98 87 99 87 98 109 97 106 
98 104 99 109 99 94 99 94 98 88 99 88 98 101 98 100 
98 112 99 100 98 96 98 74 
    
98 106 97 107 
 
 
Table C.3: Sitting wrist data set 
Subject 1 Sitting 
Wrist 
  
Subject 2 Sitting 
Wrist 
  
Subject 3 Sitting 
Wrist 
  
Subject 4 Sitting 
Wrist 
  Reference 
Oximeter Prototype 
 
Reference 
Oximter Prototype 
 
Reference 
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR SpO2 PR 
95 77 95 79 98 106 98 104 98 85 99 84 99 62 98 60 
97 79 98 80 98 106 98 107 98 87 99 88 99 61 99 63 
98 80 98 80 98 101 98 103 98 85 99 89 99 62 99 62 
98 83 98 83 98 101 98 101 98 85 99 89 99 62 99 59 
98 84 98 81 98 96 98 102 98 87 98 86 99 66 99 64 
97 80 98 81 98 98 98 101 98 87 99 89 99 62 99 74 
98 81 98 79 98 99 98 102 98 88 99 86 99 58 99 61 
98 80 98 80 98 96 98 99 98 91 99 91 99 58 99 58 
98 80 98 79 98 98 98 99 98 91 98 92 99 59 99 59 
98 80 98 80 98 99 98 101 98 92 98 89 99 58 99 59 
98 82 98 85 98 101 98 102 98 87 98 86 99 60 99 59 
98 82 98 82 98 106 99 61 98 87 99 89 99 63 99 66 
98 83 98 84 98 96 98 98 98 87 98 92 99 62 99 63 
98 84 98 84 98 96 98 99 98 87 99 86 99 67 99 63 
98 87 98 87 98 101 98 102 98 86 99 90 99 83 99 64 
98 82 99 82 98 87 98 98 98 89 99 90 99 60 99 63 
122 
 
98 82 98 81 98 88 98 96 98 91 98 89 99 60 99 61 
98 83 98 83 97 91 98 94 98 89 98 87 99 68 99 60 
98 82 98 83 98 101 98 104 98 85 99 87 99 59 99 69 
98 87 98 91 98 99 98 98 98 89 99 86 99 58 99 62 
98 84 99 82 98 96 98 99 98 91 98 86 99 59 99 59 
98 80 98 82 98 96 98 100 98 87 98 92 99 59 99 59 
98 80 98 80 98 99 98 100 98 88 98 83 99 60 99 60 
98 83 95 82 98 101 98 101 98 87 99 85 99 60 99 61 
98 84 98 85 98 101 98 101 98 83 99 87 99 57 99 61 
98 87 98 85 98 99 98 101 98 85 98 88 99 58 99 59 
98 83 98 85 98 101 98 103 98 91 98 89 99 66 99 58 
98 83 98 84 98 98 98 96 98 89 98 86 99 60 99 67 
98 83 98 85 98 98 97 100 98 85 99 84 99 59 99 60 
98 85 98 82 98 98 98 99 98 83 99 82 99 59 99 58 
98 85 98 85 98 96 98 98 98 84 99 86 99 53 99 61 
98 83 98 86 98 99 98 101 98 87 99 86 99 53 99 107 
98 83 99 84 98 98 98 95 98 83 98 86 99 63 99 68 
98 87 99 84 98 99 98 99 98 87 98 89 99 69 99 61 
98 87 98 87 98 99 98 102 98 87 99 86 99 65 99 69 
98 83 98 87 98 101 98 102 98 87 99 92 99 61 99 67 
 
Table C.4: Standing wrist data set 
Subject 1 
Standing Wrist 
  
Subject 2 
Standing Wrist 
  
Subject 3 
Standing Wrist 
  
Subject 4 
Standing Wrist 
  Reference 
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
Reference 
Oximeter Prototype 
 
SpO2 PR SpO2 PR SpO2 HR SpO2 PR SpO2 HR SpO2 PR SpO2 
Heart 
Rate SpO2 PR 
98 94 98 93 98 99 98 108 98 98 98 96 98 71 94 69 
123 
 
98 96 98 96 98 101 98 99 98 98 95 97 98 77 98 73 
98 96 99 100 98 99 98 99 98 94 95 100 98 71 98 69 
98 96 98 99 98 103 98 98 98 96 95 100 98 79 98 80 
98 98 98 97 98 103 98 101 98 99 95 91 98 84 98 83 
98 98 99 97 98 96 98 101 98 99 95 99 98 76 98 75 
98 96 98 98 98 101 98 97 98 94 95 96 98 75 98 77 
98 96 98 100 98 94 96 95 98 96 97 97 98 80 98 82 
98 98 98 97 98 95 97 88 98 94 95 96 98 77 98 79 
98 99 98 101 98 96 97 98 98 96 95 98 98 80 98 78 
98 99 98 95 98 97 98 96 98 96 96 99 98 80 98 81 
98 101 99 97 98 99 98 97 98 91 95 100 98 79 98 78 
98 101 96 98 98 101 98 101 98 94 95 92 98 75 98 80 
98 98 98 97 98 100 98 99 98 99 95 95 97 83 98 82 
98 96 99 93 98 98 99 94 98 93 95 91 98 83 98 81 
98 96 98 101 98 101 98 97 98 91 95 87 98 80 98 85 
98 98 98 98 98 103 98 99 98 88 97 106 98 77 98 82 
98 101 98 100 98 101 97 104 98 89 96 93 97 78 98 85 
98 112 99 100 98 99 97 100 98 93 95 98 97 78 98 85 
98 101 98 105 98 102 98 99 98 92 95 95 97 80 98 83 
98 91 98 85 98 103 98 104 98 96 96 95 98 78 98 73 
98 93 98 88 98 101 97 103 98 96 95 93 98 76 98 78 
98 96 97 92 98 99 98 99 98 91 96 88 98 78 98 81 
98 96 98 95 98 101 98 98 98 96 95 94 98 77 98 76 
98 98 98 100 98 104 98 100 98 90 97 88 98 83 98 86 
98 99 98 100 98 106 98 107 98 91 98 61 98 80 98 77 
98 101 98 102 98 101 98 99 98 86 99 93 98 75 98 79 
98 98 98 99 98 99 96 99 97 96 96 93 98 80 98 87 
98 103 98 98 98 99 97 99 97 91 96 91 98 76 98 81 
124 
 
98 99 98 103 98 103 98 98 97 91 95 93 98 80 98 81 
98 99 98 98 98 101 97 105 98 89 95 97 98 80 97 85 
98 98 98 103 98 104 98 100 
    
98 79 98 81 
98 101 99 101 98 108 98 105 
    
98 76 98 80 
    
98 106 98 110 
    
98 73 98 79 
    
98 96 98 105 
    
98 73 98 80 
    
98 103 98 95 
    
98 81 98 80 
 
Table C.5: Standing wrist data set 
Subject 1 
Hyperventilation 
 
Subject 2 
Hyperventilation 
 
Subject 3 
Hyperventilation 
 
Subject 4 
Hyperventilation 
 Reference 
Oximeter Prototype 
Reference 
Oximeter Prototype 
Reference 
Oximeter Prototype 
Reference 
Oximeter Prototype 
PR PR PR PR PR PR PR PR 
91 92 91 92 82 82 89 89 
91 82 89 88 81 99 85 85 
86 87 89 91 82 80 91 88 
85 85 87 86 88 87 85 80 
84 85 87 86 84 88 87 82 
80 84 87 91 87 87 89 88 
77 76 87 91 87 85 89 91 
75 53 89 90 87 78 87 79 
76 78 94 92 87 86 87 87 
80 81 96 95 87 74 87 76 
83 80 96 93 87 82 87 86 
87 84 98 100 87 79 89 87 
88 92 100 101 77 93 89 91 
94 94 96 89 76 98 90 89 
96 95 96 94 82 101 89 97 
125 
 
99 101 96 92 96 111 89 90 
101 100 91 95 99 110 87 91 
103 105 91 88 106 110 98 101 
103 104 87 95 108 107 101 94 
101 102 87 81 108 113 101 99 
101 91 92 93 106 115 101 95 
98 99 95 91 109 115 106 105 
99 94 96 97 112 118 110 110 
96 94 96 95 112 121 116 119 
96 100 98 95 115 111 120 113 
91 96 98 91 117 109 124 80 
87 91 99 90 113 97 128 126 
86 85 104 97 108 91 112 134 
87 86 104 103 103 90 112 131 
87 88 103 109 93 91 108 115 
87 88 101 108 91 92 106 109 
87 87 101 97 89 97 101 101 
87 89 91 95 91 84 99 99 
87 86 90 100 92 89 
  
87 87 96 86 89 68 
   
Table C.6: Hyperventilation data set 
Subject 1 
 
Subject 2 
 
Reference Oximeter Prototype Reference Oximeter Prototype 
SpO2 SpO2 SpO2 SpO2 
99 97 98 98 
99 97 98 98 
99 98 98 98 
126 
 
99 97 98 97 
99 97 98 98 
99 97 98 98 
99 97 98 98 
99 98 98 96 
99 97 98 98 
99 97 98 97 
99 97 97 96 
99 97 97 98 
99 96 97 98 
99 97 98 99 
99 97 98 99 
99 98 93 99 
99 97 97 93 
99 98 97 99 
99 97 98 94 
99 98 98 98 
99 98 98 97 
99 97 99 98 
99 97 95 98 
99 97 97 96 
97 96 98 99 
97 96 98 98 
96 95 98 99 
94 95 98 98 
92 94 97 98 
91 93 97 98 
94 96 96 98 
127 
 
97 96 98 99 
98 97 98 98 
97 96 98 99 
98 97 
  
98 98 
  
98 97 
  
97 97 
  
97 96 
  
97 97 
  
98 97 
  
98 96 
  
98 97 
  
98 96 
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Appendix D: Filter Bode Plots 
The bode plot in Figure D.1  was generated online using an online filter calculator which allows 
you to input the filter characteristics and the calculator will output appropriate resistor and capacitor 
values. In the case above, the filter was a bandpass filter utilized in analog form in the circuitry directly 
after the Sample-and-Hold circuits. The filters consisted of a frequency cutoff of 2Hz and a bandwidth of 
2Hz to effectively cover a range between 1Hz and 3Hz.   
 
Figure D.1: Active analog bandpass filter plot 
In Figures D.2 and D.3 we show two analog filters that were implemented in the circuitry for the 
red AC signal. We noticed that the red AC signal still contained a DC offset even after the bandpass filter 
and as a result decided to implement two more analog passive filters, one a high pass filter with an fc of 
0.1Hz and the other a low pass filter with a fc of 5.3Hz. This not only reduced the DC offset that was 
present in the red AC signal but also reduced any noise present. 
129 
 
Both Bode plots and phase diagrams were generated online through a similar calculator for RC Lowpass 
and RC High pass filters. The calculations for these filters were also done to check for errors.  
 
Figure D.2: High pass filter with fc of 0.1 Hz 
 
Figure D 3: Low pass filter with fc of 5.3 Hz 
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In Figure D.4 we show the magnitude response and the phase response of a 7
th
 order Chebyshev 
digital filter which was implemented in LabVIEW for the purpose of cleaning up the red AC signal to a 
further extent. This Bode Plot and phase diagram was generated using the Signals Toolbox in LabVIEW 
which allows one to see the magnitude response and the phase response of a filter as its being developed. 
 
 
Figure D.4: 7th order Chebyshev digital filter with low fc of 0.75 and high fc of 2.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
